candidate_genes,disease,celltype,y,user_question,full_query
"['MIF', 'RTKN', 'ZNF180', 'PDSS2', 'DICER1']",Sjogren syndrome,acinar cell of salivary gland,MIF,"Among the genes MIF, RTKN, ZNF180, PDSS2, and DICER1, which one exhibits the highest specificity in salivary gland acinar cells, making it the most promising candidate for targeted intervention in Sjögren's syndrome?","Among the genes MIF, RTKN, ZNF180, PDSS2, and DICER1, which one exhibits the highest specificity in salivary gland acinar cells, making it the most promising candidate for targeted intervention in Sjögren's syndrome? Identify the verified therapeutic targets for Sjögren syndrome and retrieve their cell type–specific embeddings from PINNACLE. Next, determine which acinar cell–activated genes from the salivary gland in PINNACLE overlap with these targets. Compute the average embedding of the overlapping genes as a reference and calculate the cosine similarity of each gene’s embedding to this reference. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CPT1A', 'CHRM3', 'LMTK3', 'MZB1', 'CCNO']",Sjogren syndrome,acinar cell of salivary gland,CHRM3,"Which gene—CPT1A, CHRM3, LMTK3, MZB1, or CCNO—exhibits the highest specificity in salivary gland acinar cells for targeted intervention in Sjogren's syndrome?","Which gene—CPT1A, CHRM3, LMTK3, MZB1, or CCNO—exhibits the highest specificity in salivary gland acinar cells for targeted intervention in Sjogren's syndrome? Identify the validated therapeutic targets for Sjögren syndrome and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which genes activated in acinar cells of the salivary gland, as captured by PINNACLE, overlap with these targets to define a set of cell-type–specific targets for the disease. Calculate the average embedding for this set as a reference, and then compute the cosine similarity between this reference and each individual target embedding. Finally, if one gene exhibits a distinctly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['CERS4', 'ABCC8', 'SMARCC2', 'TTC23L', 'RNF39']",Sjogren syndrome,acinar cell of salivary gland,SMARCC2,"Among the genes CERS4, ABCC8, SMARCC2, TTC23L, and RNF39, which one exhibits the highest specificity for acinar cells in the salivary gland, thereby representing the most promising target for Sjogren syndrome?","Among the genes CERS4, ABCC8, SMARCC2, TTC23L, and RNF39, which one exhibits the highest specificity for acinar cells in the salivary gland, thereby representing the most promising target for Sjogren syndrome? Identify validated therapeutic targets for Sjögren syndrome and extract their cell-type specific embeddings from the PINNACLE database. Next, intersect these targets with the acinar cell–specific activated genes from the salivary gland data in PINNACLE. Using this overlapping set as potential cell-type specific targets, compute the average embedding as a reference and then calculate the cosine similarity between this reference and each individual gene’s embedding. If one gene shows a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['FCGRT', 'NMNAT3', 'DSCAM', 'SRSF9', 'MYH7']",Sjogren syndrome,acinar cell of salivary gland,FCGRT,"Which gene among FCGRT, NMNAT3, DSCAM, SRSF9, and MYH7 exhibits the highest specificity for expression in salivary gland acinar cells, thereby representing the most promising target for therapeutic intervention in Sjögren’s syndrome?","Which gene among FCGRT, NMNAT3, DSCAM, SRSF9, and MYH7 exhibits the highest specificity for expression in salivary gland acinar cells, thereby representing the most promising target for therapeutic intervention in Sjögren’s syndrome? Identify the validated therapeutic targets for Sjogren syndrome and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which acinar cell–specific genes from the salivary gland in PINNACLE overlap with these targets, thereby defining a subset of cell-type–specific therapeutic candidates. Compute the average embedding of this subset, then calculate the cosine similarity between this average and each individual target’s embedding. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise evidence-based rationale for its biological relevance."
"['PYM1', 'SLC16A5', 'E2F3', 'RMC1', 'BRI3']",Sjogren syndrome,acinar cell of salivary gland,PYM1,"Which gene—PYM1, SLC16A5, E2F3, RMC1, or BRI3—exhibits the highest acinar cell-specific expression in the salivary gland, making it the most promising candidate for targeting Sjögren's syndrome?","Which gene—PYM1, SLC16A5, E2F3, RMC1, or BRI3—exhibits the highest acinar cell-specific expression in the salivary gland, making it the most promising candidate for targeting Sjögren's syndrome? Identify validated therapeutic targets for Sjögren syndrome and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which activated genes from salivary gland acinar cells in PINNACLE overlap with these targets. Compute the average embedding for the overlapping gene set and calculate the cosine similarity between this reference and the embedding of each target gene. Nominate the gene with the highest similarity as the top candidate and provide a concise evidence-based rationale for its biological relevance."
"['SNX3', 'STAC2', 'HP1BP3', 'PPIA', 'NOM1']",Sjogren syndrome,acinar cell of salivary gland,PPIA,"Which gene among SNX3, STAC2, HP1BP3, PPIA, and NOM1 exhibits the highest specificity in salivary gland acinar cells, making it the most promising candidate for targeting Sjögren's syndrome?","Which gene among SNX3, STAC2, HP1BP3, PPIA, and NOM1 exhibits the highest specificity in salivary gland acinar cells, making it the most promising candidate for targeting Sjögren's syndrome? Identify and verify therapeutic targets for Sjogren syndrome, then retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which genes activated in salivary gland acinar cells overlap with these targets, and compute the average embedding for this overlapping set as a reference. Calculate the cosine similarity between this reference and each individual target. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['UVRAG', 'SNRPD3', 'PRKACA', 'ASPSCR1', 'CTSS']",Sjogren syndrome,acinar cell of salivary gland,CTSS,"Among the following genes—UVRAG, SNRPD3, PRKACA, ASPSCR1, and CTSS—which displays the highest cell-type-specific expression in salivary gland acinar cells for potential targeted therapy in Sjogren syndrome?","Among the following genes—UVRAG, SNRPD3, PRKACA, ASPSCR1, and CTSS—which displays the highest cell-type-specific expression in salivary gland acinar cells for potential targeted therapy in Sjogren syndrome? Identify the verified therapeutic targets for Sjögren syndrome and obtain their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the acinar cell-activated genes in the salivary gland from the PINNACLE dataset to define the cell-type–specific therapeutic candidates. Calculate the average embedding for this overlapping set as a reference, then compute the cosine similarity between this reference and each individual target embedding. If one gene displays a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['KIF2C', 'PPP2R3A', 'HLA-DPB1', 'CCDC50', 'SULF1']",Sjogren syndrome,acinar cell of salivary gland,HLA-DPB1,"Which gene among KIF2C, PPP2R3A, HLA-DPB1, CCDC50, and SULF1 demonstrates the highest specificity in salivary gland acinar cells for targeted intervention in Sjögren’s syndrome?","Which gene among KIF2C, PPP2R3A, HLA-DPB1, CCDC50, and SULF1 demonstrates the highest specificity in salivary gland acinar cells for targeted intervention in Sjögren’s syndrome? Identify the verified therapeutic targets for Sjogren syndrome and retrieve their cell-type-specific embeddings from PINNACLE. Next, determine which genes activated in salivary gland acinar cells overlap with these targets, defining the cell-type-specific targets for Sjogren syndrome. Compute the average embedding of these overlapping genes to serve as a reference, then calculate the cosine similarity between this reference and each individual target’s embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['NAA35', 'FLRT3', 'OGFOD2', 'HLA-DPA1', 'CRTC3']",Sjogren syndrome,acinar cell of salivary gland,HLA-DPA1,"Among the genes NAA35, FLRT3, OGFOD2, HLA-DPA1, and CRTC3, which one exhibits the highest cell-type-specific expression in salivary gland acinar cells, making it the most promising candidate for targeting in Sjögren syndrome?","Among the genes NAA35, FLRT3, OGFOD2, HLA-DPA1, and CRTC3, which one exhibits the highest cell-type-specific expression in salivary gland acinar cells, making it the most promising candidate for targeting in Sjögren syndrome? Identify the verified therapeutic targets for Sjögren syndrome and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which activated genes in acinar cells of the salivary gland from PINNACLE overlap with these targets. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between this reference and each individual target. If one gene displays a markedly higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based rationale for its biological relevance."
"['MAGEA2', 'BICD1', 'JAK1', 'COL11A1', 'EPB41']",Sjogren syndrome,acinar cell of salivary gland,JAK1,"Which gene among MAGEA2, BICD1, JAK1, COL11A1, and EPB41 shows the highest specificity for acinar cells in the salivary gland, making it the most promising target for Sjogren syndrome?","Which gene among MAGEA2, BICD1, JAK1, COL11A1, and EPB41 shows the highest specificity for acinar cells in the salivary gland, making it the most promising target for Sjogren syndrome? Identify verified therapeutic targets for Sjögren syndrome and obtain their cell-type–specific embeddings from the PINNACLE tool. Next, determine which genes activated in salivary gland acinar cells overlap with these targets to generate a list of candidate cell-type–specific targets. Compute the average embedding across these candidates to serve as a reference profile, then calculate the cosine similarity between this reference and each individual candidate gene's embedding. If one gene shows a markedly higher similarity than the others, designate it as the top candidate. Provide a concise, evidence-based rationale for its biological relevance in the context of Sjögren syndrome."
"['PDE4A', 'IMPDH1', 'ARL2', 'CLCN7', 'FAM217B']",Sjogren syndrome,acinar cell of salivary gland,IMPDH1,"Which gene among PDE4A, IMPDH1, ARL2, CLCN7, and FAM217B displays the most selective expression in salivary gland acinar cells, thereby representing the best candidate for targeted intervention in Sjögren's syndrome?","Which gene among PDE4A, IMPDH1, ARL2, CLCN7, and FAM217B displays the most selective expression in salivary gland acinar cells, thereby representing the best candidate for targeted intervention in Sjögren's syndrome? Identify the validated therapeutic targets for Sjögren syndrome and extract their cell-type-specific embeddings from PINNACLE. Next, determine which acinar cell-activated genes from the salivary gland in PINNACLE overlap with these targets to define the cell-type-specific candidates for Sjögren syndrome. Compute the average embedding of these overlapping candidates as a reference, then calculate the cosine similarity between this reference and each candidate. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['TNR', 'SDC1', 'SUMF1', 'FSTL3', 'GTF2I']",Sjogren syndrome,acinar cell of salivary gland,GTF2I,"Which gene—TNR, SDC1, SUMF1, FSTL3, or GTF2I—exhibits the highest acinar cell specificity in the salivary gland context of Sjogren syndrome, making it the prime candidate for targeted intervention?","Which gene—TNR, SDC1, SUMF1, FSTL3, or GTF2I—exhibits the highest acinar cell specificity in the salivary gland context of Sjogren syndrome, making it the prime candidate for targeted intervention? Identify verified therapeutic targets for Sjogren syndrome and retrieve their cell-type–specific embeddings from PINNACLE. Determine which targets overlap with genes activated in salivary gland acinar cells according to PINNACLE, and compute the average embedding of this overlapping set. Then, calculate the cosine similarity between this average embedding and each individual target’s embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ZNF618', 'HLA-B', 'DCAF12', 'APOBEC3F', 'COX7A2']",Sjogren syndrome,acinar cell of salivary gland,HLA-B,"Among the genes ZNF618, HLA-B, DCAF12, APOBEC3F, and COX7A2, which exhibits the highest cell-type specificity in acinar cells of the salivary gland, making it the most promising candidate for targeting in Sjogren syndrome studies?","Among the genes ZNF618, HLA-B, DCAF12, APOBEC3F, and COX7A2, which exhibits the highest cell-type specificity in acinar cells of the salivary gland, making it the most promising candidate for targeting in Sjogren syndrome studies? Using the PINNACLE dataset, first identify validated therapeutic targets for Sjögren's syndrome and determine which of these targets overlap with genes activated in salivary gland acinar cells. Next, compute the mean embedding for this overlapping set and calculate the cosine similarity between this reference vector and each individual gene embedding. If one gene exhibits substantially higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['RCN1', 'N4BP2', 'SCGB2A1', 'ICAM3', 'RTRAF']",Sjogren syndrome,acinar cell of salivary gland,RCN1,"Among the genes RCN1, N4BP2, SCGB2A1, ICAM3, and RTRAF, which one exhibits the highest specificity in salivary gland acinar cells, making it the most promising candidate for targeted intervention in Sjogren syndrome?","Among the genes RCN1, N4BP2, SCGB2A1, ICAM3, and RTRAF, which one exhibits the highest specificity in salivary gland acinar cells, making it the most promising candidate for targeted intervention in Sjogren syndrome? Identify the validated therapeutic targets for Sjögren syndrome and retrieve their corresponding cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with acinar cell–specific activation genes in the salivary gland as defined by PINNACLE. Compute the average embedding for this overlapping set and then calculate the cosine similarity between this reference embedding and each individual target’s embedding. Finally, nominate the gene with the highest similarity as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['SEMA3A', 'PIP4K2C', 'DEFB131A', 'STAT1', 'HAPLN2']",Sjogren syndrome,acinar cell of salivary gland,STAT1,"Which gene among SEMA3A, PIP4K2C, DEFB131A, STAT1, and HAPLN2 exhibits the highest cell-type specificity in salivary gland acinar cells and could serve as a potential target for Sjogren syndrome therapy?","Which gene among SEMA3A, PIP4K2C, DEFB131A, STAT1, and HAPLN2 exhibits the highest cell-type specificity in salivary gland acinar cells and could serve as a potential target for Sjogren syndrome therapy? Identify the verified therapeutic targets for Sjögren syndrome and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine which acinar cell–activated genes in the salivary gland, as represented in PINNACLE, overlap with these targets, defining the cell-type–specific targets for Sjögren syndrome. Compute the average embedding for this overlapping set, then calculate the cosine similarity between this average reference and the embedding for each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based justification for its biological relevance."
"['CLCN4', 'HLA-DRA', 'RACK1', 'LTA4H', 'SLC7A2']",Sjogren syndrome,acinar cell of salivary gland,HLA-DRA,"Which gene—CLCN4, HLA-DRA, RACK1, LTA4H, or SLC7A2—exhibits the highest specificity for acinar cells in the salivary gland, making it the most promising target for therapeutic intervention in Sjogren's syndrome?","Which gene—CLCN4, HLA-DRA, RACK1, LTA4H, or SLC7A2—exhibits the highest specificity for acinar cells in the salivary gland, making it the most promising target for therapeutic intervention in Sjogren's syndrome? Identify experimentally validated therapeutic targets for Sjögren syndrome and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, from the set of genes upregulated in salivary gland acinar cells, determine which ones overlap with the therapeutic targets to establish a cell-type–specific set. Compute the average embedding of this subset as a reference, then calculate the cosine similarity between this reference and each individual target embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['EIF3E', 'IFNAR1', 'KCNN1', 'PIKFYVE', 'TUFM']",Sjogren syndrome,acinar cell of salivary gland,IFNAR1,"Which gene among EIF3E, IFNAR1, KCNN1, PIKFYVE, and TUFM exhibits the highest cell-type specificity in salivary gland acinar cells, thereby representing the most optimal target for Sjögren's syndrome?","Which gene among EIF3E, IFNAR1, KCNN1, PIKFYVE, and TUFM exhibits the highest cell-type specificity in salivary gland acinar cells, thereby representing the most optimal target for Sjögren's syndrome? Identify the validated therapeutic targets for Sjögren syndrome and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine the overlap between these targets and acinar cell–activated genes in the salivary gland as defined by PINNACLE. Calculate the average embedding for this overlapping set and then compute the cosine similarity between this reference embedding and each individual target’s embedding. If one gene displays a notably higher similarity than the others, nominate it as the prime candidate and provide a concise, evidence-based rationale for its biological relevance."
"['IMPDH2', 'ENPP3', 'COG4', 'ZNF280A', 'RAB41']",Sjogren syndrome,acinar cell of salivary gland,IMPDH2,"Which gene—IMPDH2, ENPP3, COG4, ZNF280A, or RAB41—demonstrates the highest specificity in acinar cells of the salivary gland for therapeutic targeting in Sjögren's syndrome?","Which gene—IMPDH2, ENPP3, COG4, ZNF280A, or RAB41—demonstrates the highest specificity in acinar cells of the salivary gland for therapeutic targeting in Sjögren's syndrome? Identify verified therapeutic targets for Sjögren syndrome and obtain their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the acinar cell-activated genes in the salivary gland data from PINNACLE to define cell-type–specific targets. Calculate the average embedding of the overlapping set, then assess the cosine similarity between this average and each individual target embedding. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['FKBP1A', 'ELF4', 'AMPD3', 'VEGFD', 'CDX2']",Sjogren syndrome,acinar cell of salivary gland,FKBP1A,"Among FKBP1A, ELF4, AMPD3, VEGFD, and CDX2, which gene shows the highest expression specificity in salivary gland acinar cells as a candidate for targeted intervention in Sjögren syndrome?","Among FKBP1A, ELF4, AMPD3, VEGFD, and CDX2, which gene shows the highest expression specificity in salivary gland acinar cells as a candidate for targeted intervention in Sjögren syndrome? What are the verified therapeutic targets for Sjogren syndrome? Retrieve their cell-type–specific embeddings from PINNACLE and determine which acinar cell-activated genes in the salivary gland overlap with these targets. Using this overlapping set as the cell-type–specific targets for Sjogren syndrome, compute their average embedding and then calculate the cosine similarity between this average and each individual gene embedding. If one gene displays a substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological significance."
"['CD40', 'KIF22', 'KLK8', 'FILIP1L', 'TUBGCP4']",Sjogren syndrome,acinar cell of salivary gland,CD40,"Among the genes CD40, KIF22, KLK8, FILIP1L, and TUBGCP4, which one exhibits the highest cell-type specificity in salivary gland acinar cells for potential targeting in Sjogren syndrome?","Among the genes CD40, KIF22, KLK8, FILIP1L, and TUBGCP4, which one exhibits the highest cell-type specificity in salivary gland acinar cells for potential targeting in Sjogren syndrome? Identify the verified therapeutic targets for Sjögren syndrome and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine which acinar cell-activated genes in the salivary gland overlap with these targets to define the cell-type–specific targets. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between this reference and each target. If one gene shows markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ZFYVE9', 'MIF', 'ELOVL5', 'RPS6', 'FAM172A']",Sjogren syndrome,iga plasma cell,MIF,"Among the genes ZFYVE9, MIF, ELOVL5, RPS6, and FAM172A, which one shows the highest specificity in IgA plasma cells, making it the most promising target for addressing Sjogren's syndrome?","Among the genes ZFYVE9, MIF, ELOVL5, RPS6, and FAM172A, which one shows the highest specificity in IgA plasma cells, making it the most promising target for addressing Sjogren's syndrome? Identify the validated therapeutic targets for Sjogren syndrome and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the set of IgA plasma cell-activated genes available in PINNACLE. Compute the average embedding for this overlapping set, then calculate the cosine similarity between this average and each individual target's embedding. If one gene exhibits a distinctly higher similarity than the others, nominate it as the prime candidate and provide a brief, evidence-based explanation of its biological relevance."
"['VWA2', 'SYPL1', 'HLA-B', 'FOXJ1', 'DCT']",Sjogren syndrome,iga plasma cell,HLA-B,"Among the genes VWA2, SYPL1, HLA-B, FOXJ1, and DCT, which one exhibits the most specific expression in IgA plasma cells, making it the most promising target for Sjögren's syndrome therapy?","Among the genes VWA2, SYPL1, HLA-B, FOXJ1, and DCT, which one exhibits the most specific expression in IgA plasma cells, making it the most promising target for Sjögren's syndrome therapy? Identify the verified therapeutic targets for Sjögren syndrome and extract their cell-type–specific embeddings from PINNACLE. Next, identify the overlap between these targets and the iga plasma cell-activated genes in PINNACLE to obtain the cell-type–specific targets. Compute the average embedding for this overlapping set and determine the cosine similarity between this average and the embedding of each individual target. If one gene exhibits a substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SLCO1B1', 'TRIM71', 'ZNF256', 'TNFAIP3', 'RELN']",Sjogren syndrome,iga plasma cell,TNFAIP3,"Among the genes SLCO1B1, TRIM71, ZNF256, TNFAIP3, and RELN, which shows the highest specificity for IgA plasma cells in the context of targeting Sjögren syndrome?","Among the genes SLCO1B1, TRIM71, ZNF256, TNFAIP3, and RELN, which shows the highest specificity for IgA plasma cells in the context of targeting Sjögren syndrome? For Sjögren's syndrome, identify validated therapeutic targets and obtain their corresponding cell-type-specific embeddings from PINNACLE. Next, determine which genes activated in IgA plasma cells, as identified in PINNACLE, overlap with these therapeutic targets. From this overlapping set, compute the average embedding vector and calculate the cosine similarity between this reference and each individual target's embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['SIX5', 'FA2H', 'PTPN21', 'CTSS', 'CLOCK']",Sjogren syndrome,iga plasma cell,CTSS,"Which gene—SIX5, FA2H, PTPN21, CTSS, or CLOCK—exhibits the highest cell-type specificity in IgA plasma cells, making it the most promising candidate for targeted intervention in Sjögren's syndrome?","Which gene—SIX5, FA2H, PTPN21, CTSS, or CLOCK—exhibits the highest cell-type specificity in IgA plasma cells, making it the most promising candidate for targeted intervention in Sjögren's syndrome? Identify verified therapeutic targets for Sjogren syndrome by retrieving their cell-type–specific embeddings from PINNACLE. Then, determine which of the previously identified Iga plasma cell–activated genes in PINNACLE overlap with these targets. For the overlapping genes, compute the average embedding to serve as a reference, and then calculate the cosine similarity between this reference and each individual gene’s embedding. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['WASH2P', 'CARD8', 'TIAM1', 'ZNF230', 'PPIA']",Sjogren syndrome,iga plasma cell,PPIA,"Which gene—WASH2P, CARD8, TIAM1, ZNF230, or PPIA—exhibits the highest cell-type specificity in IgA plasma cells, thereby representing the most promising target for addressing Sjogren syndrome?","Which gene—WASH2P, CARD8, TIAM1, ZNF230, or PPIA—exhibits the highest cell-type specificity in IgA plasma cells, thereby representing the most promising target for addressing Sjogren syndrome? Identify the validated therapeutic targets for Sjögren syndrome and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine the intersection between these targets and the set of IgA plasma cell-activated genes in PINNACLE, defining this overlapping set as the cell-type–specific targets for Sjögren syndrome. Compute the average embedding of these targets as a reference, then calculate the cosine similarity between this reference embedding and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CTSS', 'RPS23', 'SPATA33', 'COPB1', 'INHBC']",Sjogren syndrome,iga plasma cell,CTSS,"Which gene among CTSS, RPS23, SPATA33, COPB1, and INHBC displays the highest specificity to IgA plasma cells, thereby representing the most promising target for Sjögren syndrome?","Which gene among CTSS, RPS23, SPATA33, COPB1, and INHBC displays the highest specificity to IgA plasma cells, thereby representing the most promising target for Sjögren syndrome? Identify the verified therapeutic targets for Sjögren syndrome and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the iga plasma cell-activated genes in PINNACLE. Compute the average embedding of the overlapping genes as a reference, and then calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a significantly higher cosine similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['DCANP1', 'WAC', 'MIF', 'FUNDC2', 'FZD8']",Sjogren syndrome,iga plasma cell,MIF,"Among the genes DCANP1, WAC, MIF, FUNDC2, and FZD8, which exhibits the highest cell-type specificity in IgA plasma cells as a potential target for Sjögren's syndrome therapy?","Among the genes DCANP1, WAC, MIF, FUNDC2, and FZD8, which exhibits the highest cell-type specificity in IgA plasma cells as a potential target for Sjögren's syndrome therapy? Identify the verified therapeutic targets for Sjögren syndrome and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of the IgA plasma cell–activated genes in PINNACLE overlap with these targets to obtain a set of cell-type–specific targets for the syndrome. Compute the average embedding of this overlapping set to establish a reference profile, then calculate the cosine similarity between this reference and each individual target embedding. If one gene demonstrates a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PPIA', 'PKNOX2', 'MON1A', 'INTS8', 'RNF144A']",Sjogren syndrome,iga plasma cell,PPIA,"Which gene among PPIA, PKNOX2, MON1A, INTS8, and RNF144A exhibits the highest cell-type specificity in IgA plasma cells and represents the best candidate for targeting Sjögren syndrome?","Which gene among PPIA, PKNOX2, MON1A, INTS8, and RNF144A exhibits the highest cell-type specificity in IgA plasma cells and represents the best candidate for targeting Sjögren syndrome? Identify verified therapeutic targets for Sjogren syndrome and retrieve their cell-type–specific embeddings from PINNACLE. Determine which of these targets overlap with the set of IgA plasma cell–activated genes available in PINNACLE. These overlapping genes represent the cell-type–specific targets for Sjogren syndrome. Compute the average embedding of this set and calculate the cosine similarity between this reference and each individual target. If one gene shows a notably higher similarity than the others, nominate it as the top candidate, providing a concise, evidence-based rationale for its biological relevance."
"['GABRQ', 'TNFAIP3', 'PLA2G12A', 'IFT172', 'STK19']",Sjogren syndrome,iga plasma cell,TNFAIP3,"Which gene among GABRQ, TNFAIP3, PLA2G12A, IFT172, and STK19 exhibits the highest cell-type-specific expression in IgA plasma cells for targeting Sjögren syndrome?","Which gene among GABRQ, TNFAIP3, PLA2G12A, IFT172, and STK19 exhibits the highest cell-type-specific expression in IgA plasma cells for targeting Sjögren syndrome? Identify verified therapeutic targets for Sjogren syndrome and obtain their cell-type-specific embeddings from PINNACLE. Next, identify which of the iga plasma cell-activated genes in PINNACLE overlap with these targets to define the cell-type-specific targets for the syndrome. Calculate the average embedding of this overlapping set to serve as a reference, and then compute the cosine similarity between this reference and each individual target's embedding. If one gene exhibits a notably higher similarity than the others, nominate it as the prime candidate and provide a concise, evidence-based rationale for its biological relevance."
"['VCL', 'HLA-B', 'GRM3', 'ERCC8', 'UTP14A']",Sjogren syndrome,iga plasma cell,HLA-B,"Among VCL, HLA-B, GRM3, ERCC8, and UTP14A, which gene exhibits the highest specificity in IgA plasma cells and therefore represents the most promising target for Sjögren's syndrome intervention?","Among VCL, HLA-B, GRM3, ERCC8, and UTP14A, which gene exhibits the highest specificity in IgA plasma cells and therefore represents the most promising target for Sjögren's syndrome intervention? Identify the validated therapeutic targets for Sjogren syndrome and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of the Iga plasma cell–activated genes in PINNACLE overlap with these targets, forming a set of cell-type–specific targets for Sjogren syndrome. Compute the average embedding of this overlapping set to serve as a reference, then calculate the cosine similarity between this reference and each individual overlapping target. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TIMM22', 'THBS1', 'DCST1', 'SPAG1', 'HLA-B']",Sjogren syndrome,iga plasma cell,HLA-B,"Which gene among TIMM22, THBS1, DCST1, SPAG1, and HLA-B exhibits the most cell-type specific expression in IgA plasma cells relevant to targeting Sjögren syndrome?","Which gene among TIMM22, THBS1, DCST1, SPAG1, and HLA-B exhibits the most cell-type specific expression in IgA plasma cells relevant to targeting Sjögren syndrome? Identify authenticated therapeutic targets for Sjogren syndrome and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the set of iga plasma cell–activated genes available in PINNACLE, thereby defining the cell-type–specific targets for Sjogren syndrome. Compute the average embedding of this overlapping group as a reference vector, and calculate the cosine similarity between this average and the embedding of each individual gene. Finally, if one gene shows a markedly higher similarity than the others, nominate it as the top candidate, providing a concise, evidence-based rationale for its biological relevance in Sjogren syndrome."
"['CTSS', 'CCR9', 'ATP6V1H', 'PHC3', 'HSPA13']",Sjogren syndrome,iga plasma cell,CTSS,"Which gene among CTSS, CCR9, ATP6V1H, PHC3, and HSPA13 exhibits the most cell-type–specific expression in IgA plasma cells relevant to Sjögren syndrome?","Which gene among CTSS, CCR9, ATP6V1H, PHC3, and HSPA13 exhibits the most cell-type–specific expression in IgA plasma cells relevant to Sjögren syndrome? Retrieve the verified therapeutic targets for Sjögren syndrome along with their cell-type–specific embeddings from PINNACLE. Next, identify the overlap between these targets and the Iga plasma cell-activated genes in PINNACLE to define cell-type–specific targets for Sjögren syndrome. Compute the average embedding of this overlapping set and then calculate the cosine similarity between this average and the embedding of each individual target gene. If one gene shows a substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['OR2T6', 'NQO1', 'PPIA', 'CBFA2T2', 'ZNF384']",Sjogren syndrome,iga plasma cell,PPIA,"Which gene among OR2T6, NQO1, PPIA, CBFA2T2, and ZNF384 shows the highest specificity for IgA plasma cells, thereby representing the most promising candidate for targeted intervention in Sjögren's syndrome?","Which gene among OR2T6, NQO1, PPIA, CBFA2T2, and ZNF384 shows the highest specificity for IgA plasma cells, thereby representing the most promising candidate for targeted intervention in Sjögren's syndrome? Identify the validated therapeutic targets for Sjogren syndrome and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine which targets overlap with the IgA plasma cell–activated gene set in PINNACLE. Calculate the average embedding for this overlapping set and then compute the cosine similarity between this reference embedding and each individual target. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['TNFAIP3', 'CDH5', 'SUN5', 'ZMAT4', 'SNX27']",Sjogren syndrome,iga plasma cell,TNFAIP3,"Which gene among TNFAIP3, CDH5, SUN5, ZMAT4, and SNX27 exhibits the highest specificity to IgA plasma cells in the context of targeting Sjögren’s syndrome?","Which gene among TNFAIP3, CDH5, SUN5, ZMAT4, and SNX27 exhibits the highest specificity to IgA plasma cells in the context of targeting Sjögren’s syndrome? Identify the validated therapeutic targets for Sjogren's syndrome and extract their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the IgA plasma cell-activated genes in PINNACLE to define the cell-type–specific targets for the syndrome. Compute the average embedding of this overlapping set, then calculate the cosine similarity between this reference and each target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SULT2B1', 'SLC9A3', 'GDE1', 'MIF', 'TCF25']",Sjogren syndrome,iga plasma cell,MIF,"Among the genes SULT2B1, SLC9A3, GDE1, MIF, and TCF25, which exhibits the highest cell-type specificity in IgA plasma cells and would be the most promising candidate for targeting Sjögren's syndrome?","Among the genes SULT2B1, SLC9A3, GDE1, MIF, and TCF25, which exhibits the highest cell-type specificity in IgA plasma cells and would be the most promising candidate for targeting Sjögren's syndrome? Identify the validated therapeutic targets for Sjögren syndrome and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the genes activated in IgA plasma cells within PINNACLE; this overlapping set defines the cell-type–specific targets for Sjögren syndrome. Compute the average embedding for these overlapping genes as a reference, then calculate the cosine similarity between this reference and each individual target. If one gene demonstrates a markedly higher similarity compared to the others, nominate it as the top candidate, providing a concise evidence-based rationale for its biological significance."
"['E2F7', 'H2AB3', 'MIB2', 'IL27', 'TNFAIP3']",Sjogren syndrome,iga plasma cell,TNFAIP3,"Which gene among E2F7, H2AB3, MIB2, IL27, and TNFAIP3 exhibits the greatest specificity in IgA plasma cells, indicating its potential as the most appropriate target for Sjögren syndrome?","Which gene among E2F7, H2AB3, MIB2, IL27, and TNFAIP3 exhibits the greatest specificity in IgA plasma cells, indicating its potential as the most appropriate target for Sjögren syndrome? Using PINNACLE, identify the verified therapeutic targets for Sjogren syndrome and extract their cell type–specific embeddings. Next, determine which of the Iga plasma cell–activated genes in the database overlap with these targets. Compute the average embedding from this overlapping set as a reference, and calculate the cosine similarity between this reference and each individual target embedding. If one gene shows markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['CHD6', 'ZNF334', 'BTBD8', 'STK36', 'HLA-B']",Sjogren syndrome,iga plasma cell,HLA-B,"Among CHD6, ZNF334, BTBD8, STK36, and HLA-B, which gene exhibits the highest cell-type specificity in IgA plasma cells, making it the most suitable candidate for targeting in Sjögren's syndrome?","Among CHD6, ZNF334, BTBD8, STK36, and HLA-B, which gene exhibits the highest cell-type specificity in IgA plasma cells, making it the most suitable candidate for targeting in Sjögren's syndrome? Identify the verified therapeutic targets for Sjogren syndrome and retrieve their cell-type–specific embeddings from PINNACLE. Determine the overlap between these targets and the genes activated in IgA plasma cells from PINNACLE to define cell-type–specific targets. Compute the average embedding for this overlapping set and calculate the cosine similarity between this reference vector and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance in Sjogren syndrome."
"['PLA2G4F', 'EXOC6', 'GPA33', 'UBXN8', 'MIF']",Sjogren syndrome,iga plasma cell,MIF,"Which gene among PLA2G4F, EXOC6, GPA33, UBXN8, and MIF exhibits the highest specificity in IgA plasma cells, making it the most promising candidate for targeting Sjogren's syndrome?","Which gene among PLA2G4F, EXOC6, GPA33, UBXN8, and MIF exhibits the highest specificity in IgA plasma cells, making it the most promising candidate for targeting Sjogren's syndrome? Using PINNACLE, retrieve confirmed therapeutic targets for Sjogren syndrome along with their cell-type–specific embeddings. Identify the genes that are activated in IgA plasma cells and overlap with these targets. For this overlapping set, compute the average embedding and then calculate the cosine similarity between this reference embedding and each individual gene embedding. If one gene demonstrates a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['GNE', 'ATG101', 'PPIA', 'SKA3', 'REP15']",Sjogren syndrome,iga plasma cell,PPIA,"Among the genes GNE, ATG101, PPIA, SKA3, and REP15, which one shows the highest specificity to IgA plasma cells and is the best candidate for targeting in Sjogren syndrome?","Among the genes GNE, ATG101, PPIA, SKA3, and REP15, which one shows the highest specificity to IgA plasma cells and is the best candidate for targeting in Sjogren syndrome? Which verified therapeutic targets for Sjögren syndrome have cell-type–specific embeddings in PINNACLE that overlap with the set of igA plasma cell–activated genes? Using the overlapping targets, compute their average embedding as a reference and calculate the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher similarity compared to the others, nominate it as the prime candidate and provide a concise, evidence-based rationale for its biological relevance."
"['HGFAC', 'MYO1D', 'CTSS', 'COL10A1', 'SPP1']",Sjogren syndrome,iga plasma cell,CTSS,"Which gene among HGFAC, MYO1D, CTSS, COL10A1, and SPP1 demonstrates the highest expression specificity in IgA plasma cells, making it the most promising candidate for targeting Sjogren syndrome?","Which gene among HGFAC, MYO1D, CTSS, COL10A1, and SPP1 demonstrates the highest expression specificity in IgA plasma cells, making it the most promising candidate for targeting Sjogren syndrome? Determine the verified therapeutic targets for Sjogren syndrome and retrieve their cell-type-specific embeddings from the PINNACLE dataset. Next, identify the overlapping genes between these targets and the iga plasma cell-activated genes in PINNACLE to define the cell-type-specific therapeutic targets. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between this average and each individual gene’s embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SLC25A1', 'NDUFA7', 'CYBC1', 'RCN1', 'CYP11B1']",Sjogren syndrome,endothelial cell,RCN1,"Which gene among SLC25A1, NDUFA7, CYBC1, RCN1, and CYP11B1 exhibits the highest endothelial cell-specific expression, making it the optimal candidate for targeted therapeutic interventions in Sjögren syndrome?","Which gene among SLC25A1, NDUFA7, CYBC1, RCN1, and CYP11B1 exhibits the highest endothelial cell-specific expression, making it the optimal candidate for targeted therapeutic interventions in Sjögren syndrome? Identify the verified therapeutic targets for Sjögren syndrome and obtain their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the endothelial cell–activated genes in PINNACLE, defining this intersection as the cell-type–specific targets for Sjögren syndrome. Compute the average embedding for this set and calculate the cosine similarity between the average embedding and each individual target. If one gene exhibits a significantly higher similarity relative to the others, nominate it as the primary candidate and provide a concise, evidence-based explanation of its biological significance."
"['HLA-DPA1', 'LCE3C', 'H2AC6', 'PLA2G1B', 'QSER1']",Sjogren syndrome,endothelial cell,HLA-DPA1,"Which gene among HLA-DPA1, LCE3C, H2AC6, PLA2G1B, and QSER1 demonstrates the highest endothelial cell-specific expression relevant to targeting Sjogren syndrome?","Which gene among HLA-DPA1, LCE3C, H2AC6, PLA2G1B, and QSER1 demonstrates the highest endothelial cell-specific expression relevant to targeting Sjogren syndrome? Identify the experimentally validated therapeutic targets for Sjögren syndrome and extract their cell-type–specific embeddings from PINNACLE. Then, among the endothelial cell–activated genes in PINNACLE, determine which ones overlap with these targets. Compute the average embedding of the overlapping genes and calculate the cosine similarity between this average and each individual target’s embedding. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['MACIR', 'HMGCR', 'NOS2', 'IFNAR1', 'C9orf24']",Sjogren syndrome,endothelial cell,IFNAR1,"Which gene among MACIR, HMGCR, NOS2, IFNAR1, and C9orf24 exhibits the highest specificity for endothelial cells, thereby representing the most promising candidate for targeted intervention in Sjögren syndrome?","Which gene among MACIR, HMGCR, NOS2, IFNAR1, and C9orf24 exhibits the highest specificity for endothelial cells, thereby representing the most promising candidate for targeted intervention in Sjögren syndrome? Identify validated therapeutic targets for Sjögren syndrome and obtain their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which of these targets overlap with the endothelial cell–activated gene set in PINNACLE to define the cell-type–specific targets. Compute the average embedding from this overlapping set and calculate the cosine similarity between the average embedding and each individual gene embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the prime candidate and provide a concise, evidence-based rationale for its biological relevance."
"['C3orf62', 'TMOD4', 'SNURF', 'NR3C1', 'RAB39B']",Sjogren syndrome,endothelial cell,NR3C1,"Which gene among C3orf62, TMOD4, SNURF, NR3C1, and RAB39B exhibits the highest endothelial cell-specific expression, making it the most promising target for treating Sjögren's syndrome?","Which gene among C3orf62, TMOD4, SNURF, NR3C1, and RAB39B exhibits the highest endothelial cell-specific expression, making it the most promising target for treating Sjögren's syndrome? Identify the validated therapeutic targets for Sjogren syndrome and extract their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the endothelial cell-activated genes in PINNACLE, defining these as the cell-type–specific targets. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between the reference and each individual target gene. Finally, if one gene exhibits a substantially higher cosine similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['ADGRL4', 'TRB', 'GTF2I', 'VGLL2', 'WDR12']",Sjogren syndrome,endothelial cell,GTF2I,"Among the genes ADGRL4, TRB, GTF2I, VGLL2, and WDR12, which one exhibits the highest specificity of expression in endothelial cells for targeting Sjögren's syndrome?","Among the genes ADGRL4, TRB, GTF2I, VGLL2, and WDR12, which one exhibits the highest specificity of expression in endothelial cells for targeting Sjögren's syndrome? Identify the validated therapeutic targets for Sjogren syndrome and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with the endothelial cell-activated genes in PINNACLE to define the relevant cell-type–specific targets. Calculate the average embedding of this overlapping set as a reference vector, then compute the cosine similarity between this reference and each individual embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['TSN', 'SMCP', 'MRPL55', 'FAM120B', 'JAK1']",Sjogren syndrome,endothelial cell,JAK1,"Among the genes TSN, SMCP, MRPL55, FAM120B, and JAK1, which one exhibits the highest degree of endothelial cell-specific expression for potential targeted intervention in Sjogren's syndrome?","Among the genes TSN, SMCP, MRPL55, FAM120B, and JAK1, which one exhibits the highest degree of endothelial cell-specific expression for potential targeted intervention in Sjogren's syndrome? Identify validated therapeutic targets for Sjögren syndrome and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which endothelial cell-activated genes in PINNACLE overlap with these targets, thereby defining the Sjögren syndrome-specific target set. Calculate the average embedding for this set and compute the cosine similarity between this average and each individual target embedding. If one gene exhibits considerably higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['WDR20', 'STK39', 'ANOS1', 'DDX6', 'JAG2']",Sjogren syndrome,endothelial cell,DDX6,"Which gene among WDR20, STK39, ANOS1, DDX6, and JAG2 demonstrates the highest endothelial cell-specific expression, thereby representing the most promising candidate for targeted intervention in Sjogren's syndrome?","Which gene among WDR20, STK39, ANOS1, DDX6, and JAG2 demonstrates the highest endothelial cell-specific expression, thereby representing the most promising candidate for targeted intervention in Sjogren's syndrome? Using verified therapeutic targets for Sjogren syndrome and their cell-type–specific embeddings from PINNACLE, identify which endothelial cell-activated genes from PINNACLE overlap these targets. Compute the average embedding for the overlapping genes, then calculate the cosine similarity between this average and each individual target embedding. If one gene exhibits a significantly higher cosine similarity compared to the others, nominate it as the primary candidate and provide a concise, evidence-based justification for its biological relevance."
"['PRICKLE3', 'PPIA', 'PYGL', 'PPP3R1', 'EIF2AK3']",Sjogren syndrome,endothelial cell,PPIA,"Which gene among PRICKLE3, PPIA, PYGL, PPP3R1, and EIF2AK3 exhibits the most specific expression in endothelial cells and is best suited for targeting therapeutic interventions in Sjogren syndrome?","Which gene among PRICKLE3, PPIA, PYGL, PPP3R1, and EIF2AK3 exhibits the most specific expression in endothelial cells and is best suited for targeting therapeutic interventions in Sjogren syndrome? Identify the experimentally verified therapeutic targets for Sjogren syndrome and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which of these targets overlap with endothelial cell–activated genes and compute the average embedding for this overlapping set. Finally, calculate the cosine similarity between this reference embedding and each individual target, and if one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate, providing a concise evidence-based rationale for its biological relevance."
"['BAZ2A', 'CYC1', 'AKR1C2', 'GHRL', 'ARCN1']",Sjogren syndrome,endothelial cell,BAZ2A,"Among the candidate genes BAZ2A, CYC1, AKR1C2, GHRL, and ARCN1, which one exhibits the highest endothelial cell-type specificity with potential relevance for targeted intervention in Sjogren syndrome?","Among the candidate genes BAZ2A, CYC1, AKR1C2, GHRL, and ARCN1, which one exhibits the highest endothelial cell-type specificity with potential relevance for targeted intervention in Sjogren syndrome? Identify all verified therapeutic targets for Sjogren syndrome and obtain their cell-type–specific embeddings from PINNACLE. Next, identify the subset of these targets that overlap with endothelial cell-activated genes in PINNACLE. For this overlapping set, compute the average embedding to serve as a reference and then calculate the cosine similarity between each gene’s embedding and this average. Identify the gene with a markedly higher similarity as the top candidate, and provide a concise, evidence-based rationale for its biological relevance."
"['IFNAR1', 'PTGES3', 'METTL17', 'ZNF77', 'HCN4']",Sjogren syndrome,endothelial cell,IFNAR1,"Among the genes IFNAR1, PTGES3, METTL17, ZNF77, and HCN4, which one shows the most specific expression in endothelial cells, making it a promising target for Sjogren syndrome therapy?","Among the genes IFNAR1, PTGES3, METTL17, ZNF77, and HCN4, which one shows the most specific expression in endothelial cells, making it a promising target for Sjogren syndrome therapy? Identify validated therapeutic targets for Sjögren syndrome and extract their cell-type–specific embeddings from PINNACLE. Then, determine the intersection of these targets with the endothelial cell-activated genes in PINNACLE to define a cell-type–specific gene set for Sjögren syndrome. Compute the average embedding for this overlapping set and calculate the cosine similarity between the average and each individual gene embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['GYS1', 'CHST7', 'MKI67', 'ADCY10', 'DDX6']",Sjogren syndrome,endothelial cell,DDX6,"Which gene among GYS1, CHST7, MKI67, ADCY10, and DDX6 displays the highest endothelial cell-type specificity, making it the most promising candidate for targeting Sjögren's syndrome?","Which gene among GYS1, CHST7, MKI67, ADCY10, and DDX6 displays the highest endothelial cell-type specificity, making it the most promising candidate for targeting Sjögren's syndrome? Identify the verified therapeutic targets for Sjogren syndrome and extract their cell-type specific embeddings from the PINNACLE platform. Next, determine the overlap between these targets and the endothelial cell-activated genes in PINNACLE. For the overlapping set, compute the average embedding as a reference vector and then calculate the cosine similarity between this vector and each individual target’s embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a succinct, evidence-based rationale for its biological relevance."
"['FOXD4L6', 'AGMAT', 'PPIA', 'CTR9', 'WDR74']",Sjogren syndrome,endothelial cell,PPIA,"Which gene among FOXD4L6, AGMAT, PPIA, CTR9, and WDR74 exhibits the highest specificity in endothelial cells, making it the optimal target for therapeutic intervention in Sjögren syndrome?","Which gene among FOXD4L6, AGMAT, PPIA, CTR9, and WDR74 exhibits the highest specificity in endothelial cells, making it the optimal target for therapeutic intervention in Sjögren syndrome? Identify the verified therapeutic targets for Sjogren syndrome from PINNACLE's cell-type-specific embeddings and determine which of these targets overlap with genes activated in endothelial cells. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between the reference and each individual target's embedding. If one gene clearly exhibits higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['PDGFA', 'EIF4H', 'CCDC40', 'RCN1', 'CHMP4A']",Sjogren syndrome,endothelial cell,RCN1,"Among the genes PDGFA, EIF4H, CCDC40, RCN1, and CHMP4A, which one exhibits the highest endothelial cell-specific expression for potential targeting in Sjögren's syndrome?","Among the genes PDGFA, EIF4H, CCDC40, RCN1, and CHMP4A, which one exhibits the highest endothelial cell-specific expression for potential targeting in Sjögren's syndrome? Identify the validated therapeutic targets for Sjogren syndrome and extract their cell‐type–specific embeddings from PINNACLE. Then, determine which endothelial cell‐activated genes in PINNACLE overlap with these targets and compute the average embedding for this overlapping set. Finally, calculate the cosine similarity between each individual target’s embedding and the average embedding, and if one gene shows a markedly higher similarity than the others, nominate it as the top candidate with a concise, evidence‐based explanation for its biological relevance."
"['GTF2I', 'MRPL49', 'KDM2A', 'PHOSPHO1', 'ARF3']",Sjogren syndrome,endothelial cell,GTF2I,"Among GTF2I, MRPL49, KDM2A, PHOSPHO1, and ARF3, which gene exhibits the most specific expression in endothelial cells, making it the most promising candidate for targeted intervention in Sjögren’s syndrome?","Among GTF2I, MRPL49, KDM2A, PHOSPHO1, and ARF3, which gene exhibits the most specific expression in endothelial cells, making it the most promising candidate for targeted intervention in Sjögren’s syndrome? Identify verified therapeutic targets for Sjogren syndrome and retrieve their cell-type specific embeddings from PINNACLE. Next, determine the overlap between these targets and the endothelial cell-activated genes in PINNACLE to define a set of cell-type specific therapeutic targets for Sjogren syndrome. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between this average and each individual target's embedding. If one gene shows a significantly higher similarity than all others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SEM1', 'VWC2L', 'DNAH7', 'KLHL38', 'JAK1']",Sjogren syndrome,endothelial cell,JAK1,"Among the genes SEM1, VWC2L, DNAH7, KLHL38, and JAK1, which exhibits the highest specificity in endothelial cells and represents the most promising candidate target for Sjögren’s syndrome research?","Among the genes SEM1, VWC2L, DNAH7, KLHL38, and JAK1, which exhibits the highest specificity in endothelial cells and represents the most promising candidate target for Sjögren’s syndrome research? Identify the validated therapeutic targets for Sjögren syndrome and retrieve their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which of the endothelial cell–activated genes in PINNACLE overlap with these targets, considering this overlapping set as the cell-type–specific targets for Sjögren syndrome. Compute the average embedding of this overlapping set and calculate the cosine similarity between this reference and the embedding of each target gene. If one gene demonstrates substantially higher similarity than the others, nominate it as the primary candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NDUFAF3', 'SPATA20', 'RCAN1', 'PEF1', 'HLA-DPA1']",Sjogren syndrome,endothelial cell,HLA-DPA1,"Among the genes NDUFAF3, SPATA20, RCAN1, PEF1, and HLA-DPA1, which one exhibits the highest endothelial cell-specific expression, making it the most promising candidate for targeted intervention in Sjogren syndrome?","Among the genes NDUFAF3, SPATA20, RCAN1, PEF1, and HLA-DPA1, which one exhibits the highest endothelial cell-specific expression, making it the most promising candidate for targeted intervention in Sjogren syndrome? Identify the verified therapeutic targets for Sjögren syndrome and retrieve their cell-type–specific embeddings from PINNACLE. Next, filter for those endothelial cell-activated genes in PINNACLE that overlap with these therapeutic targets. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['ZNF85', 'BAZ2A', 'HEXD', 'KLHL40', 'GABRA2']",Sjogren syndrome,endothelial cell,BAZ2A,"Which gene among ZNF85, BAZ2A, HEXD, KLHL40, and GABRA2 exhibits the highest cell-type specificity in endothelial cells for potential targeting in Sjogren syndrome?","Which gene among ZNF85, BAZ2A, HEXD, KLHL40, and GABRA2 exhibits the highest cell-type specificity in endothelial cells for potential targeting in Sjogren syndrome? Identify validated therapeutic targets for Sjögren syndrome and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with endothelial cell–activated genes in PINNACLE, and compute their average embedding as a reference profile. Then calculate the cosine similarity between this reference and each target’s embedding. If one gene exhibits substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance in Sjögren syndrome."
"['NR3C1', 'PCSK5', 'SF3A2', 'SEPTIN14', 'CWC25']",Sjogren syndrome,endothelial cell,NR3C1,"Among the genes NR3C1, PCSK5, SF3A2, SEPTIN14, and CWC25, which one exhibits the highest endothelial cell-specific expression, making it the most promising single candidate for targeting Sjogren syndrome?","Among the genes NR3C1, PCSK5, SF3A2, SEPTIN14, and CWC25, which one exhibits the highest endothelial cell-specific expression, making it the most promising single candidate for targeting Sjogren syndrome? Identify verified therapeutic targets for Sjogren syndrome and obtain their cell-type–specific embeddings from PINNACLE. Compare these with endothelial cell-activated genes in PINNACLE to determine the overlapping set representing cell-type–specific targets. Compute the average embedding of this set as a reference and calculate the cosine similarity of each individual target's embedding to this reference. If one gene exhibits a distinctly higher similarity, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['DNAJA1', 'FGF17', 'DDX6', 'GJD2', 'DLK1']",Sjogren syndrome,endothelial cell,DDX6,"Which gene among DNAJA1, FGF17, DDX6, GJD2, and DLK1 shows the highest endothelial cell-specific expression for potential targeting in Sjögren syndrome?","Which gene among DNAJA1, FGF17, DDX6, GJD2, and DLK1 shows the highest endothelial cell-specific expression for potential targeting in Sjögren syndrome? Identify validated therapeutic targets for Sjögren syndrome and obtain their cell-type–specific embeddings from PINNACLE. Next, identify the overlap between these targets and the endothelial cell–activated genes in the database. Compute the average embedding for this overlapping set and calculate the cosine similarity between the average and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ZNF414', 'C2orf74', 'BRD1', 'WDR11', 'HLA-DPA1']",Sjogren syndrome,endothelial cell,HLA-DPA1,"Which gene among ZNF414, C2orf74, BRD1, WDR11, and HLA-DPA1 exhibits the highest specificity for endothelial cells as a target relevant to Sjogren syndrome?","Which gene among ZNF414, C2orf74, BRD1, WDR11, and HLA-DPA1 exhibits the highest specificity for endothelial cells as a target relevant to Sjogren syndrome? Identify the confirmed therapeutic targets for Sjögren syndrome and extract their cell-type specific embeddings from PINNACLE. Determine which of these targets overlap with PINNACLE’s endothelial cell-activated genes, providing the cell-type specific targets for Sjögren syndrome. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between this reference and each individual target’s embedding. If one gene shows significantly greater similarity than the others, nominate it as the top candidate and provide a brief, evidence-based explanation of its biological relevance."
"['BRI3', 'PDS5B', 'PPIA', 'STOML1', 'SMAD9']",Sjogren syndrome,duct epithelial cell,PPIA,"Which gene among BRI3, PDS5B, PPIA, STOML1, and SMAD9 exhibits the greatest cell-type specificity in duct epithelial cells, making it the most promising candidate for targeting Sjögren's syndrome?","Which gene among BRI3, PDS5B, PPIA, STOML1, and SMAD9 exhibits the greatest cell-type specificity in duct epithelial cells, making it the most promising candidate for targeting Sjögren's syndrome? Identify the verified therapeutic targets for Sjogren syndrome and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which of the duct epithelial cell–activated genes in PINNACLE overlap with these targets to define the cell-type specific targets for Sjogren syndrome. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between this reference and each individual target. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MTCH2', 'BOLL', 'HLA-DPB1', 'CPN1', 'DSN1']",Sjogren syndrome,duct epithelial cell,HLA-DPB1,"Among the genes MTCH2, BOLL, HLA-DPB1, CPN1, and DSN1, which exhibits the highest cell-type specificity for duct epithelial cells in the context of Sjogren syndrome?","Among the genes MTCH2, BOLL, HLA-DPB1, CPN1, and DSN1, which exhibits the highest cell-type specificity for duct epithelial cells in the context of Sjogren syndrome? Identify the validated therapeutic targets for Sjögren syndrome and obtain their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which duct epithelial cell-activated genes overlap with these targets and designate this overlapping set as the cell-type–specific targets for Sjögren syndrome. Compute the average embedding of these genes as a reference, and then calculate the cosine similarity between this reference and each individual target embedding. If one gene demonstrates a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['GPR26', 'IMPDH2', 'ZFYVE9', 'AHSA1', 'DCAF8']",Sjogren syndrome,duct epithelial cell,IMPDH2,"Among the genes GPR26, IMPDH2, ZFYVE9, AHSA1, and DCAF8, which exhibits the highest cell-type specificity in duct epithelial cells as a candidate target for Sjögren's syndrome?","Among the genes GPR26, IMPDH2, ZFYVE9, AHSA1, and DCAF8, which exhibits the highest cell-type specificity in duct epithelial cells as a candidate target for Sjögren's syndrome? Identify the validated therapeutic targets for Sjogren syndrome and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine the overlap between these targets and the set of duct epithelial cell-activated genes in PINNACLE to define a group of cell-type–specific targets. Calculate the average embedding for this group and compute the cosine similarity between this average and each individual target embedding. If one gene exhibits a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['DCUN1D3', 'HLA-DRA', 'FAM98A', 'DEFB105A', 'JAZF1']",Sjogren syndrome,duct epithelial cell,HLA-DRA,"Among the candidate genes DCUN1D3, HLA-DRA, FAM98A, DEFB105A, and JAZF1, which exhibits the greatest cell-type specificity in ductal epithelial cells for potential targeting in Sjögren’s syndrome?","Among the candidate genes DCUN1D3, HLA-DRA, FAM98A, DEFB105A, and JAZF1, which exhibits the greatest cell-type specificity in ductal epithelial cells for potential targeting in Sjögren’s syndrome? Identify the verified therapeutic targets for Sjögren syndrome and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with genes activated in duct epithelial cells as annotated in PINNACLE. Compute the average embedding of the overlapping genes to serve as a reference, and then calculate the cosine similarity between this reference and each individual gene’s embedding. If one gene shows a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance in Sjögren syndrome."
"['TEX43', 'TSC2', 'ZNF558', 'FCGRT', 'MAPKAPK3']",Sjogren syndrome,duct epithelial cell,FCGRT,"Among the genes TEX43, TSC2, ZNF558, FCGRT, and MAPKAPK3, which one exhibits the highest cell-type specificity in ductal epithelial cells, making it the most promising candidate for targeting in Sjögren’s syndrome?","Among the genes TEX43, TSC2, ZNF558, FCGRT, and MAPKAPK3, which one exhibits the highest cell-type specificity in ductal epithelial cells, making it the most promising candidate for targeting in Sjögren’s syndrome? Identify all verified therapeutic targets for Sjögren syndrome and extract their cell-type–specific embeddings from PINNACLE. Next, determine which duct epithelial cell-activated genes in PINNACLE overlap with these targets to define cell-type–specific therapeutic targets. Compute the average embedding from this overlapping set and calculate the cosine similarity between this reference and the embedding of each target gene. If one gene exhibits a substantially higher similarity compared to the others, nominate it as the top candidate, providing a brief, evidence-based rationale for its biological significance."
"['CAVIN4', 'TRMT1', 'U2AF1L5', 'HLA-B', 'MED9']",Sjogren syndrome,duct epithelial cell,HLA-B,"Among the genes CAVIN4, TRMT1, U2AF1L5, HLA-B, and MED9, which shows the highest cell-type specificity in duct epithelial cells and is the most promising target for Sjögren syndrome?","Among the genes CAVIN4, TRMT1, U2AF1L5, HLA-B, and MED9, which shows the highest cell-type specificity in duct epithelial cells and is the most promising target for Sjögren syndrome? What are the validated therapeutic targets for Sjögren syndrome, and how are their cell-type-specific embeddings represented in the PINNACLE database? Retrieve the embeddings for those targets expressed specifically in activated duct epithelial cells and determine the overlap between these and the activated duct epithelial genes in PINNACLE. Calculate the average embedding for the overlapping set, then compute the cosine similarity between this average and each individual target’s embedding. If one gene shows a markedly higher similarity, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['GABPB1', 'IMPDH2', 'SEL1L3', 'MSH3', 'RGP1']",Sjogren syndrome,duct epithelial cell,IMPDH2,"Which gene among GABPB1, IMPDH2, SEL1L3, MSH3, and RGP1 exhibits the most duct epithelial cell-specific expression in the context of targeting Sjogren syndrome?","Which gene among GABPB1, IMPDH2, SEL1L3, MSH3, and RGP1 exhibits the most duct epithelial cell-specific expression in the context of targeting Sjogren syndrome? Identify verified therapeutic targets for Sjogren syndrome and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with genes activated in duct epithelial cells in PINNACLE to define a set of cell‐type–specific targets for Sjogren syndrome. Compute the average embedding of these overlapping genes as a reference, then calculate the cosine similarity between this reference and each individual target embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['HLA-B', 'DENND2D', 'PTH2R', 'PAGE2', 'FGFBP1']",Sjogren syndrome,duct epithelial cell,HLA-B,"Among the genes HLA-B, DENND2D, PTH2R, PAGE2, and FGFBP1, which one exhibits the highest expression specificity in ductal epithelial cells relevant to targeting Sjögren's syndrome?","Among the genes HLA-B, DENND2D, PTH2R, PAGE2, and FGFBP1, which one exhibits the highest expression specificity in ductal epithelial cells relevant to targeting Sjögren's syndrome? Identify the validated therapeutic targets for Sjögren syndrome and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, identify the overlap between these targets and genes activated in duct epithelial cells. Calculate the average embedding of this overlapping set to serve as a reference, and compute the cosine similarity between this reference and the embedding of each target gene. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['PPIA', 'PHC1', 'NCR3', 'PTGES3L-AARSD1', 'KHDRBS3']",Sjogren syndrome,duct epithelial cell,PPIA,"Among the genes PPIA, PHC1, NCR3, PTGES3L-AARSD1, and KHDRBS3, which one exhibits the highest expression specificity in duct epithelial cells, making it a promising candidate for targeted therapeutic approaches in Sjögren's syndrome?","Among the genes PPIA, PHC1, NCR3, PTGES3L-AARSD1, and KHDRBS3, which one exhibits the highest expression specificity in duct epithelial cells, making it a promising candidate for targeted therapeutic approaches in Sjögren's syndrome? Identify the verified therapeutic targets for Sjogren syndrome and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which duct epithelial cell-activated genes overlap with these targets to define a subset of cell-type–specific targets. Compute the average embedding of this subset, then calculate the cosine similarity between this average and each individual gene’s embedding. If one gene exhibits substantially higher similarity than the others, designate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['OAS1', 'NAPA', 'HLA-DPB1', 'PRDM2', 'TSPAN2']",Sjogren syndrome,duct epithelial cell,HLA-DPB1,"Which gene among OAS1, NAPA, HLA-DPB1, PRDM2, and TSPAN2 exhibits the highest specificity in ductal epithelial cells relevant to targeting Sjögren's syndrome?","Which gene among OAS1, NAPA, HLA-DPB1, PRDM2, and TSPAN2 exhibits the highest specificity in ductal epithelial cells relevant to targeting Sjögren's syndrome? Identify validated therapeutic targets for Sjogren syndrome and obtain their cell-type–specific embeddings from the PINNACLE dataset. Next, determine the set of duct epithelial cell–activated genes within PINNACLE that overlap with these targets, defining the Sjogren syndrome cell-type–specific targets. Compute the average embedding of these overlapping genes as a reference vector, and then calculate the cosine similarity between this reference and each target embedding. If one gene shows a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SLCO1C1', 'HLA-DRA', 'RAB1C', 'MIPOL1', 'ADAMTSL4']",Sjogren syndrome,duct epithelial cell,HLA-DRA,"Which gene among SLCO1C1, HLA-DRA, RAB1C, MIPOL1, and ADAMTSL4 exhibits the most pronounced cell-type-specific expression in duct epithelial cells for targeting Sjögren's syndrome?","Which gene among SLCO1C1, HLA-DRA, RAB1C, MIPOL1, and ADAMTSL4 exhibits the most pronounced cell-type-specific expression in duct epithelial cells for targeting Sjögren's syndrome? Determine the validated therapeutic targets for Sjogren syndrome and obtain their cell-type–specific embeddings from PINNACLE. Next, identify the overlap between these targets and the genes activated in duct epithelial cells within the same dataset. Using this overlapping set as the cell-type–specific targets, compute the average embedding vector and then calculate the cosine similarity between this vector and each individual target. If one gene shows a significantly higher similarity than all others, nominate it as the best candidate and provide a concise, evidence-based explanation for its biological relevance."
"['TGM5', 'FCGRT', 'ABCF1', 'IFITM10', 'FGF17']",Sjogren syndrome,duct epithelial cell,FCGRT,"Which gene among TGM5, FCGRT, ABCF1, IFITM10, and FGF17 shows the greatest specificity for duct epithelial cells, making it the most promising target in Sjogren's syndrome studies?","Which gene among TGM5, FCGRT, ABCF1, IFITM10, and FGF17 shows the greatest specificity for duct epithelial cells, making it the most promising target in Sjogren's syndrome studies? Identify the verified therapeutic targets for Sjogren syndrome and obtain their cell-type–specific embeddings from PINNACLE. From these targets, determine which ones overlap with the genes activated in duct epithelial cells, then compute the average embedding of the overlapping set. Next, calculate the cosine similarity between this average embedding and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance in Sjogren syndrome."
"['NFRKB', 'HLA-B', 'CCL3L3', 'TMEM208', 'LOXL2']",Sjogren syndrome,duct epithelial cell,HLA-B,"Which gene, among NFRKB, HLA-B, CCL3L3, TMEM208, and LOXL2, exhibits the highest specificity in duct epithelial cells for targeting Sjögren syndrome?","Which gene, among NFRKB, HLA-B, CCL3L3, TMEM208, and LOXL2, exhibits the highest specificity in duct epithelial cells for targeting Sjögren syndrome? Identify validated therapeutic targets for Sjögren syndrome and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine which genes activated in duct epithelial cells overlap with these targets, defining the cell-type–specific Sjögren syndrome targets. Compute the average embedding of this overlapping set, then calculate the cosine similarity between this average and the embedding of each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the prime candidate and provide a concise, evidence-based rationale for its biological relevance."
"['POLD1', 'BIRC7', 'SPINK7', 'HLA-DRA', 'SPP1']",Sjogren syndrome,duct epithelial cell,HLA-DRA,"Which gene among POLD1, BIRC7, SPINK7, HLA-DRA, and SPP1 shows the highest specificity for duct epithelial cells and is most suitable for targeted studies in Sjögren's syndrome?","Which gene among POLD1, BIRC7, SPINK7, HLA-DRA, and SPP1 shows the highest specificity for duct epithelial cells and is most suitable for targeted studies in Sjögren's syndrome? Identify verified therapeutic targets for Sjogren syndrome and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the duct epithelial cell-activated genes in PINNACLE. For the overlapping genes, compute the average embedding vector and determine the cosine similarity between this average and each individual gene embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['EPHA7', 'HABP2', 'RP1', 'FCGRT', 'STX4']",Sjogren syndrome,duct epithelial cell,FCGRT,"Which gene among EPHA7, HABP2, RP1, FCGRT, and STX4 exhibits the highest cell-type specific expression in duct epithelial cells for targeted intervention in Sjogren's syndrome?","Which gene among EPHA7, HABP2, RP1, FCGRT, and STX4 exhibits the highest cell-type specific expression in duct epithelial cells for targeted intervention in Sjogren's syndrome? Identify the verified therapeutic targets for Sjogren syndrome and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which duct epithelial cell-activated genes in PINNACLE overlap with these targets to define the cell-type–specific targets for Sjogren syndrome. Compute the average embedding for this overlap set as a reference and calculate the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['PRPF6', 'S100A8', 'POLQ', 'PPIA', 'DONSON']",Sjogren syndrome,duct epithelial cell,PPIA,"Which gene among PRPF6, S100A8, POLQ, PPIA, and DONSON exhibits the highest expression specificity in ductal epithelial cells, indicating its potential as a targeted candidate for Sjögren's syndrome?","Which gene among PRPF6, S100A8, POLQ, PPIA, and DONSON exhibits the highest expression specificity in ductal epithelial cells, indicating its potential as a targeted candidate for Sjögren's syndrome? Identify verified therapeutic targets for Sjögren syndrome and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of the duct epithelial cell-activated genes in PINNACLE overlap with these targets to define the cell-type–specific targets for Sjögren syndrome. Compute the average embedding for these overlapping genes as a reference, then calculate the cosine similarity between this reference and each individual target. Finally, if one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['DCAF5', 'MID1IP1', 'IMPDH2', 'HK1', 'ARHGAP15']",Sjogren syndrome,duct epithelial cell,IMPDH2,"Which gene among DCAF5, MID1IP1, IMPDH2, HK1, and ARHGAP15 exhibits the highest cell-type specificity in ductal epithelial cells relevant to Sjögren's syndrome?","Which gene among DCAF5, MID1IP1, IMPDH2, HK1, and ARHGAP15 exhibits the highest cell-type specificity in ductal epithelial cells relevant to Sjögren's syndrome? Using validated therapeutic targets for Sjogren syndrome, retrieve their cell-type–specific embeddings from PINNACLE and identify which duct epithelial cell-activated genes overlap with these targets. Next, calculate the average embedding of this overlapping gene set and compute the cosine similarity between this average and each individual target. If one gene exhibits a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ABI3', 'FH', 'HLA-DPB1', 'DNAJB12', 'GABPB2']",Sjogren syndrome,duct epithelial cell,HLA-DPB1,"Which gene—ABI3, FH, HLA-DPB1, DNAJB12, or GABPB2—demonstrates the highest cell-type specificity in duct epithelial cells relevant to Sjögren syndrome targeting?","Which gene—ABI3, FH, HLA-DPB1, DNAJB12, or GABPB2—demonstrates the highest cell-type specificity in duct epithelial cells relevant to Sjögren syndrome targeting? Identify verified therapeutic targets for Sjögren syndrome and extract their cell-type–specific embeddings from PINNACLE. Then, determine the overlap between PINNACLE’s duct epithelial cell–activated gene set and these targets to define cell-type–specific targets for the disease. Compute the average embedding of this overlapping set as a reference, and calculate the cosine similarity between this reference and each individual target. If one gene exhibits substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NPTX1', 'ESRRA', 'FITM2', 'IL32', 'FCGRT']",Sjogren syndrome,duct epithelial cell,FCGRT,"Which gene among NPTX1, ESRRA, FITM2, IL32, and FCGRT demonstrates the highest specificity in duct epithelial cells, making it the most promising candidate for targeted therapy in Sjögren syndrome?","Which gene among NPTX1, ESRRA, FITM2, IL32, and FCGRT demonstrates the highest specificity in duct epithelial cells, making it the most promising candidate for targeted therapy in Sjögren syndrome? Identify known therapeutic targets for Sjögren syndrome and obtain their cell-type–specific embeddings from the PINNACLE database. Next, identify the overlap between these targets and genes activated in duct epithelial cells in PINNACLE, defining the cell-type–specific targets for Sjögren syndrome. Compute the average embedding of this overlapping set, then calculate the cosine similarity between this reference and each individual target. If one gene shows significantly higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based rationale for its biological relevance."
"['PCDH18', 'RTN3', 'HLA-B', 'GAGE1', 'ADH1B']",Sjogren syndrome,duct epithelial cell,HLA-B,"Which gene among PCDH18, RTN3, HLA-B, GAGE1, and ADH1B demonstrates the highest cell-type specificity in duct epithelial cells as a candidate target for Sjögren syndrome?","Which gene among PCDH18, RTN3, HLA-B, GAGE1, and ADH1B demonstrates the highest cell-type specificity in duct epithelial cells as a candidate target for Sjögren syndrome? Identify the validated therapeutic targets for Sjogren syndrome and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine which of the duct epithelial cell-activated genes in PINNACLE overlap with these targets. Calculate the average embedding for this overlapping set and compute the cosine similarity between this average and each individual target embedding. If one gene exhibits a distinctly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance in Sjogren syndrome."
"['TMEM243', 'KLK8', 'ZBTB21', 'MIF', 'HSH2D']",Sjogren syndrome,myoepithelial cell,MIF,"Among the genes TMEM243, KLK8, ZBTB21, MIF, and HSH2D, which one exhibits the highest cell-type specificity in myoepithelial cells for targeting Sjogren syndrome?","Among the genes TMEM243, KLK8, ZBTB21, MIF, and HSH2D, which one exhibits the highest cell-type specificity in myoepithelial cells for targeting Sjogren syndrome? Identify verified therapeutic targets for Sjögren syndrome and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which myoepithelial cell-activated genes in the dataset overlap with these targets, thus defining the cell-type–specific targets for Sjögren syndrome. Compute the average embedding as a reference and calculate the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['HMGN5', 'HPCAL4', 'HOXD3', 'FCGRT', 'ZBTB48']",Sjogren syndrome,myoepithelial cell,FCGRT,"Which gene among HMGN5, HPCAL4, HOXD3, FCGRT, and ZBTB48 exhibits the highest specificity for myoepithelial cells, thereby representing the most promising single candidate for targeting in Sjögren's syndrome?","Which gene among HMGN5, HPCAL4, HOXD3, FCGRT, and ZBTB48 exhibits the highest specificity for myoepithelial cells, thereby representing the most promising single candidate for targeting in Sjögren's syndrome? Identify all verified therapeutic targets for Sjogren syndrome and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the set of myoepithelial cell-activated genes in PINNACLE. Using the overlap as the cell-type–specific targets for Sjogren syndrome, compute their average embedding as a reference and calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ASIC4', 'PPIA', 'AMY1B', 'HMGA1', 'PARD6B']",Sjogren syndrome,myoepithelial cell,PPIA,"Among the genes ASIC4, PPIA, AMY1B, HMGA1, and PARD6B, which exhibits the highest specificity of expression in myoepithelial cells, making it the most promising candidate for therapeutic targeting in Sjogren’s syndrome?","Among the genes ASIC4, PPIA, AMY1B, HMGA1, and PARD6B, which exhibits the highest specificity of expression in myoepithelial cells, making it the most promising candidate for therapeutic targeting in Sjogren’s syndrome? Identify and validate therapeutic targets for Sjogren syndrome using cell-type–specific embeddings from PINNACLE. Determine which myoepithelial cell-activated genes overlap with these targets. Next, compute the average embedding for this overlapping set as a reference and calculate the cosine similarity between this reference and each target gene’s embedding. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SNRPC', 'NBPF26', 'HOXC11', 'HLA-B', 'VTI1B']",Sjogren syndrome,myoepithelial cell,HLA-B,"Among SNRPC, NBPF26, HOXC11, HLA-B, and VTI1B, which gene shows the highest specificity in myoepithelial cells and represents the most promising target for Sjögren’s syndrome?","Among SNRPC, NBPF26, HOXC11, HLA-B, and VTI1B, which gene shows the highest specificity in myoepithelial cells and represents the most promising target for Sjögren’s syndrome? Identify the validated therapeutic targets for Sjogren syndrome and retrieve their cell-type-specific embeddings from the PINNACLE database. Next, determine which myoepithelial cell-activated genes in PINNACLE overlap with these targets, thereby defining the cell-type-specific targets for Sjogren syndrome. Compute the average embedding of this overlapping gene set and calculate the cosine similarity between this reference and each individual target. If one gene displays significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['VAX2', 'F8', 'GLB1L2', 'JAK1', 'GUCD1']",Sjogren syndrome,myoepithelial cell,JAK1,"Which gene among VAX2, F8, GLB1L2, JAK1, and GUCD1 exhibits the highest specificity of expression in myoepithelial cells, making it the most promising candidate for targeting in Sjögren syndrome?","Which gene among VAX2, F8, GLB1L2, JAK1, and GUCD1 exhibits the highest specificity of expression in myoepithelial cells, making it the most promising candidate for targeting in Sjögren syndrome? Identify the verified therapeutic targets for Sjögren syndrome and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine the intersection between these targets and the genes activated in myoepithelial cells as recorded in PINNACLE. Compute the average embedding for this overlapping gene set to serve as a reference, then calculate the cosine similarity between this reference vector and the embedding of each individual target gene. If one gene exhibits a significantly higher similarity than all others, nominate it as the top candidate and provide a concise, evidence-based explanation of its likely biological relevance."
"['FKBP1A', 'GTF2H1', 'MLNR', 'TMEM231', 'HOOK1']",Sjogren syndrome,myoepithelial cell,FKBP1A,"Which gene among FKBP1A, GTF2H1, MLNR, TMEM231, and HOOK1 exhibits the greatest cell-type specificity in myoepithelial cells, making it the optimal candidate for targeting in Sjögren syndrome?","Which gene among FKBP1A, GTF2H1, MLNR, TMEM231, and HOOK1 exhibits the greatest cell-type specificity in myoepithelial cells, making it the optimal candidate for targeting in Sjögren syndrome? Identify the validated therapeutic targets for Sjögren's syndrome and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which myoepithelial cell-activated genes (as identified in PINNACLE) overlap with these targets to define the cell-type–specific targets for the syndrome. Calculate the average embedding of this overlapping set and then compute the cosine similarity between this average and each individual target's embedding. If one gene exhibits a substantially higher similarity than the others, nominate that gene as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['RPS17', 'PLCD3', 'COL4A5', 'JAK1', 'VANGL1']",Sjogren syndrome,myoepithelial cell,JAK1,"Of the genes RPS17, PLCD3, COL4A5, JAK1, and VANGL1, which one exhibits the highest myoepithelial cell specificity for potential therapeutic targeting in Sjögren syndrome?","Of the genes RPS17, PLCD3, COL4A5, JAK1, and VANGL1, which one exhibits the highest myoepithelial cell specificity for potential therapeutic targeting in Sjögren syndrome? Identify the verified therapeutic targets for Sjogren syndrome and retrieve their cell-type–specific embeddings from PINNACLE. Determine which myoepithelial cell-activated genes in PINNACLE overlap with these targets. Compute the average embedding of the overlapping set and calculate the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological significance."
"['GRIK2', 'RBM11', 'HLA-B', 'MYH9', 'SLC48A1']",Sjogren syndrome,myoepithelial cell,HLA-B,"Which of the following candidate genes—GRIK2, RBM11, HLA-B, MYH9, or SLC48A1—exhibits the highest specificity of expression in myoepithelial cells, making it the most promising target for Sjögren’s syndrome intervention?","Which of the following candidate genes—GRIK2, RBM11, HLA-B, MYH9, or SLC48A1—exhibits the highest specificity of expression in myoepithelial cells, making it the most promising target for Sjögren’s syndrome intervention? Identify verified therapeutic targets for Sjögren syndrome and extract their cell-type–specific embeddings from PINNACLE. Next, determine which myoepithelial cell-activated genes in PINNACLE overlap with these targets to define a cell-type–specific gene set for Sjögren syndrome. Compute the average embedding for this overlapping set as a reference, then calculate the cosine similarity between this reference and each individual gene's embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based rationale for its biological relevance."
"['ERCC6L', 'MRPS36', 'RAD52', 'FKBP1A', 'LIN28B']",Sjogren syndrome,myoepithelial cell,FKBP1A,"Among the genes ERCC6L, MRPS36, RAD52, FKBP1A, and LIN28B, which one exhibits the highest specificity in myoepithelial cells for targeted intervention in Sjögren’s syndrome?","Among the genes ERCC6L, MRPS36, RAD52, FKBP1A, and LIN28B, which one exhibits the highest specificity in myoepithelial cells for targeted intervention in Sjögren’s syndrome? Identify those therapeutic targets for Sjogren syndrome that have been validated and obtain their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which of these targets overlap with the genes activated in myoepithelial cells within PINNACLE. For the overlapping genes, compute their average embedding and calculate the cosine similarity between this average and each individual target’s embedding. If one gene shows a substantially higher similarity score than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['VAV2', 'PITPNA', 'GOLGA5', 'FCGRT', 'TBC1D5']",Sjogren syndrome,myoepithelial cell,FCGRT,"Among the candidate genes VAV2, PITPNA, GOLGA5, FCGRT, and TBC1D5, which one exhibits the highest specificity in myoepithelial cells, making it the most promising target for interventions in Sjögren's syndrome?","Among the candidate genes VAV2, PITPNA, GOLGA5, FCGRT, and TBC1D5, which one exhibits the highest specificity in myoepithelial cells, making it the most promising target for interventions in Sjögren's syndrome? Identify the verified therapeutic targets for Sjogren syndrome and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the myoepithelial cell–activated genes from PINNACLE to define the set of cell-type–specific targets. Calculate the average embedding of this overlapping set as a reference, then compute the cosine similarity between the reference and each individual target. If one gene shows significantly higher similarity than the others, nominate it as the top candidate and provide an evidence-based rationale for its biological relevance."
"['PPIA', 'VAPA', 'CPXM2', 'CTRC', 'OPN1SW']",Sjogren syndrome,myoepithelial cell,PPIA,"Which gene among PPIA, VAPA, CPXM2, CTRC, and OPN1SW exhibits the highest specificity for myoepithelial cells, making it the most promising candidate for targeting in Sjogren syndrome?","Which gene among PPIA, VAPA, CPXM2, CTRC, and OPN1SW exhibits the highest specificity for myoepithelial cells, making it the most promising candidate for targeting in Sjogren syndrome? Determine the verified therapeutic targets for Sjogren syndrome and obtain their cell-type–specific embeddings from PINNACLE. Identify the overlap between these targets and myoepithelial cell–active genes in PINNACLE, thereby defining cell-type–specific therapeutic targets. Calculate the average embedding for this overlapping set, and then compute the cosine similarity between this average and the embedding of each individual gene. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate, providing a concise, evidence-based justification for its biological relevance."
"['H4C6', 'C4A', 'TRIB3', 'MIF', 'CTTNBP2']",Sjogren syndrome,myoepithelial cell,MIF,"Among the genes H4C6, C4A, TRIB3, MIF, and CTTNBP2, which exhibits the highest specificity of expression in myoepithelial cells and should be considered the prime candidate for targeting Sjögren syndrome?","Among the genes H4C6, C4A, TRIB3, MIF, and CTTNBP2, which exhibits the highest specificity of expression in myoepithelial cells and should be considered the prime candidate for targeting Sjögren syndrome? Identify verified therapeutic targets for Sjogren syndrome in the PINNACLE dataset and extract their cell-type–specific embeddings. Next, intersect these targets with genes activated in myoepithelial cells to obtain a set of cell-type–specific targets. Compute the average embedding of these targets and then calculate the cosine similarity between this reference and each individual target. If one gene shows significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['FAM90A1', 'KLK2', 'CORO6', 'JAK1', 'SLC1A5']",Sjogren syndrome,myoepithelial cell,JAK1,"Which gene among FAM90A1, KLK2, CORO6, JAK1, and SLC1A5 shows the highest specificity for myoepithelial cells in the context of Sjogren syndrome targeting?","Which gene among FAM90A1, KLK2, CORO6, JAK1, and SLC1A5 shows the highest specificity for myoepithelial cells in the context of Sjogren syndrome targeting? Identify verified therapeutic targets for Sjogren syndrome and extract their cell-type–specific embedding data from PINNACLE. Determine which of these targets overlap with the myoepithelial cell-activated genes in PINNACLE. Next, compute the average embedding of the overlapping set as a reference, and calculate the cosine similarity between this average and each individual target embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the prime candidate and provide a concise, evidence-based explanation for its biological relevance."
"['SART3', 'TUBA3C', 'HLA-B', 'IFNL3', 'KRT75']",Sjogren syndrome,myoepithelial cell,HLA-B,"Among the genes SART3, TUBA3C, HLA-B, IFNL3, and KRT75, which one demonstrates the highest specificity for myoepithelial cells in the context of targeting Sjögren syndrome?","Among the genes SART3, TUBA3C, HLA-B, IFNL3, and KRT75, which one demonstrates the highest specificity for myoepithelial cells in the context of targeting Sjögren syndrome? Identify the validated therapeutic targets for Sjogren syndrome and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which myoepithelial cell-activated genes in PINNACLE overlap with these targets, defining the cell-type–specific targets for Sjogren syndrome. Compute the average embedding of this overlapping set as a reference and calculate the cosine similarity between this reference and each individual target gene. Finally, if one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SPEG', 'KRT25', 'FCGRT', 'PERP', 'ACHE']",Sjogren syndrome,myoepithelial cell,FCGRT,"Which gene among SPEG, KRT25, FCGRT, PERP, and ACHE exhibits the most specific expression in myoepithelial cells, making it the optimal candidate for targeting Sjogren syndrome?","Which gene among SPEG, KRT25, FCGRT, PERP, and ACHE exhibits the most specific expression in myoepithelial cells, making it the optimal candidate for targeting Sjogren syndrome? Using PINNACLE, identify verified therapeutic targets for Sjogren syndrome and extract their cell-type–specific embeddings. Next, determine which therapeutic targets overlap with genes activated in myoepithelial cells. For this overlapping set, compute the average embedding to serve as a reference, then calculate the cosine similarity between this reference and each individual target gene. If a single gene exhibits a notably higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['FKBP1A', 'PCDHA4', 'DAPK1', 'EEF1AKMT3', 'SDF4']",Sjogren syndrome,myoepithelial cell,FKBP1A,"Which gene, among FKBP1A, PCDHA4, DAPK1, EEF1AKMT3, and SDF4, exhibits the highest cell-type specificity in myoepithelial cells for targeted intervention in Sjogren syndrome?","Which gene, among FKBP1A, PCDHA4, DAPK1, EEF1AKMT3, and SDF4, exhibits the highest cell-type specificity in myoepithelial cells for targeted intervention in Sjogren syndrome? Identify the validated therapeutic targets for Sjögren syndrome and extract their cell-type-specific embeddings from the PINNACLE dataset. Next, determine which myoepithelial cell-activated genes in PINNACLE overlap with these therapeutic targets, and compute the average embedding for this overlapping set. Then, calculate the cosine similarity between this average embedding and the individual target embeddings. If a single gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['PPIA', 'RMI2', 'DIXDC1', 'ZCCHC14', 'SELENOP']",Sjogren syndrome,myoepithelial cell,PPIA,"Which gene among PPIA, RMI2, DIXDC1, ZCCHC14, and SELENOP exhibits the highest cell-type specificity in myoepithelial cells, making it the most promising candidate for targeted therapy in Sjögren’s syndrome?","Which gene among PPIA, RMI2, DIXDC1, ZCCHC14, and SELENOP exhibits the highest cell-type specificity in myoepithelial cells, making it the most promising candidate for targeted therapy in Sjögren’s syndrome? Identify the verified therapeutic targets for Sjogren syndrome and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine which myoepithelial cell-activated genes in PINNACLE overlap with these targets to define cell-type–specific targets. Compute the average embedding vector for this set and calculate the cosine similarity between this reference and each individual target. If one gene exhibits a substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['ZP4', 'DNAJC7', 'MIF', 'CNN3', 'ASPH']",Sjogren syndrome,myoepithelial cell,MIF,"Among the genes ZP4, DNAJC7, MIF, CNN3, and ASPH, which one exhibits the highest specificity for myoepithelial cells, making it the prime candidate for targeted intervention in Sjögren's syndrome?","Among the genes ZP4, DNAJC7, MIF, CNN3, and ASPH, which one exhibits the highest specificity for myoepithelial cells, making it the prime candidate for targeted intervention in Sjögren's syndrome? Identify and verify the therapeutic targets for Sjogren syndrome and obtain their cell type–specific embeddings from the PINNACLE database. Next, determine which myoepithelial cell–activated genes in PINNACLE overlap with these targets and compute the average embedding for this overlapping set. Finally, calculate the cosine similarity between this average embedding and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['FKBP1A', 'CSPP1', 'SPO11', 'HIKESHI', 'INTS9']",Sjogren syndrome,myoepithelial cell,FKBP1A,"Among FKBP1A, CSPP1, SPO11, HIKESHI, and INTS9, which gene exhibits the highest specificity in myoepithelial cells for potential targeting in Sjogren’s syndrome?","Among FKBP1A, CSPP1, SPO11, HIKESHI, and INTS9, which gene exhibits the highest specificity in myoepithelial cells for potential targeting in Sjogren’s syndrome? Identify validated therapeutic targets for Sjogren syndrome and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine which of the genes activated in myoepithelial cells in PINNACLE overlap with these targets to define the cell-type–specific targets for the syndrome. Calculate the mean embedding for this overlapping set and compute the cosine similarity between this reference and each individual target. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CDC42SE1', 'CDK12', 'JAK1', 'CDIPT', 'UMAD1']",Sjogren syndrome,myoepithelial cell,JAK1,"Among the genes CDC42SE1, CDK12, JAK1, CDIPT, and UMAD1, which one exhibits the highest myoepithelial cell-specific expression and could serve as a potential target for Sjogren syndrome treatment?","Among the genes CDC42SE1, CDK12, JAK1, CDIPT, and UMAD1, which one exhibits the highest myoepithelial cell-specific expression and could serve as a potential target for Sjogren syndrome treatment? Identify the validated therapeutic targets for Sjögren syndrome and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of the myoepithelial cell-activated genes in PINNACLE overlap with these targets, forming the cell-type–specific target set for Sjögren syndrome. Calculate the average embedding of this set as a reference, then compute the cosine similarity between this reference and each target’s embedding. If one gene shows significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['NEURL2', 'F11', 'FKBP1A', 'KRT222', 'PGM3']",Sjogren syndrome,fibroblast,FKBP1A,"Which gene among NEURL2, F11, FKBP1A, KRT222, and PGM3 exhibits the highest fibroblast-specific expression, making it the most promising target for Sjogren's syndrome research?","Which gene among NEURL2, F11, FKBP1A, KRT222, and PGM3 exhibits the highest fibroblast-specific expression, making it the most promising target for Sjogren's syndrome research? Identify the validated therapeutic targets for Sjogren syndrome and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine the intersection of these targets with fibroblast-activated genes in PINNACLE to define the cell-type–specific targets for Sjogren syndrome. Compute the average embedding of this overlapping set, then calculate the cosine similarity between this average and each individual gene’s embedding. If one gene exhibits a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['JAK1', 'PIMREG', 'MAN2A2', 'TBCB', 'UBE2W']",Sjogren syndrome,fibroblast,JAK1,"Among the genes JAK1, PIMREG, MAN2A2, TBCB, and UBE2W, which one exhibits the most robust fibroblast-specific expression to serve as a potential target for Sjögren syndrome?","Among the genes JAK1, PIMREG, MAN2A2, TBCB, and UBE2W, which one exhibits the most robust fibroblast-specific expression to serve as a potential target for Sjögren syndrome? Identify the validated therapeutic targets for Sjogren syndrome and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which fibroblast-activated genes in PINNACLE overlap with these targets, thereby defining the cell-type–specific targets for Sjogren syndrome. Calculate the average embedding of this overlapping set to use as a reference and compute the cosine similarity between this reference and each individual target. Finally, if one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['SIX2', 'NR3C1', 'EP400', 'SH3PXD2A', 'SLC16A3']",Sjogren syndrome,fibroblast,NR3C1,"Which gene among SIX2, NR3C1, EP400, SH3PXD2A, and SLC16A3 exhibits the most fibroblast-specific expression relevant for targeting Sjögren syndrome?","Which gene among SIX2, NR3C1, EP400, SH3PXD2A, and SLC16A3 exhibits the most fibroblast-specific expression relevant for targeting Sjögren syndrome? Determine the verified therapeutic targets for Sjogren syndrome and extract their cell-type–specific embeddings from the PINNACLE dataset. Identify which of these targets overlap with the fibroblast-activated genes in PINNACLE. For the overlapping set, compute the average embedding to serve as a reference profile, and then calculate the cosine similarity between this reference and each individual gene. If one gene exhibits substantially higher similarity than the others, designate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PAX9', 'HSF1', 'SLC34A1', 'MRTFA', 'HLA-DRA']",Sjogren syndrome,fibroblast,HLA-DRA,"Which gene among PAX9, HSF1, SLC34A1, MRTFA, and HLA-DRA exhibits the highest fibroblast-specific expression, making it the most promising candidate for targeting in Sjögren syndrome?","Which gene among PAX9, HSF1, SLC34A1, MRTFA, and HLA-DRA exhibits the highest fibroblast-specific expression, making it the most promising candidate for targeting in Sjögren syndrome? Identify the verified therapeutic targets for Sjogren syndrome and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the fibroblast-activated genes in PINNACLE to define the cell-type–specific targets for Sjogren syndrome. Compute the average embedding for this overlapping set and calculate the cosine similarity between this reference and each individual target. If one gene exhibits substantially higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['TMEM171', 'POU5F1P3', 'UMAD1', 'NCAPD2', 'BAZ2A']",Sjogren syndrome,fibroblast,BAZ2A,"Among TMEM171, POU5F1P3, UMAD1, NCAPD2, and BAZ2A, which gene exhibits the highest fibroblast-specific expression and thus represents the most promising target for therapeutic intervention in Sjogren's syndrome?","Among TMEM171, POU5F1P3, UMAD1, NCAPD2, and BAZ2A, which gene exhibits the highest fibroblast-specific expression and thus represents the most promising target for therapeutic intervention in Sjogren's syndrome? Identify verified therapeutic targets for Sjögren syndrome and extract their cell-type-specific embeddings from PINNACLE. Next, determine which fibroblast-activated genes in PINNACLE overlap with these targets to define the cell-type-specific targets for Sjögren syndrome. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between this reference and each individual target. If one gene shows substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['CLDN9', 'RCN1', 'H1-2', 'ANXA5', 'H2AC1']",Sjogren syndrome,fibroblast,RCN1,"Among CLDN9, RCN1, H1-2, ANXA5, and H2AC1, which gene shows the highest fibroblast-specific expression linked to Sjogren's syndrome targeting?","Among CLDN9, RCN1, H1-2, ANXA5, and H2AC1, which gene shows the highest fibroblast-specific expression linked to Sjogren's syndrome targeting? Identify the verified therapeutic targets for Sjögren syndrome and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which fibroblast-activated genes in PINNACLE overlap with these targets, defining this intersection as the cell-type–specific targets for Sjögren syndrome. Calculate the average embedding of these targets to serve as a reference, then compute the cosine similarity between this reference and each individual target. If one gene consistently exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['GTF2I', 'ACACA', 'DIABLO', 'KDELR3', 'PRPF18']",Sjogren syndrome,fibroblast,GTF2I,"Which gene among GTF2I, ACACA, DIABLO, KDELR3, and PRPF18 exhibits the highest fibroblast cell-type specificity relevant to targeting Sjögren's syndrome?","Which gene among GTF2I, ACACA, DIABLO, KDELR3, and PRPF18 exhibits the highest fibroblast cell-type specificity relevant to targeting Sjögren's syndrome? Identify all experimentally verified therapeutic targets for Sjogren syndrome and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with fibroblast-activated genes in PINNACLE, and compute the average embedding of this overlapping set. Then, calculate the cosine similarity between the average embedding and each individual target’s embedding. If one gene exhibits a significantly higher similarity relative to the others, nominate it as the top candidate and provide a concise, evidence-based justification for its biological relevance."
"['DDX10', 'RND1', 'IFNAR1', 'KLHL29', 'ZFYVE21']",Sjogren syndrome,fibroblast,IFNAR1,"Among DDX10, RND1, IFNAR1, KLHL29, and ZFYVE21, which gene demonstrates the highest fibroblast-specific expression relevant to targeting Sjögren's syndrome?","Among DDX10, RND1, IFNAR1, KLHL29, and ZFYVE21, which gene demonstrates the highest fibroblast-specific expression relevant to targeting Sjögren's syndrome? Identify validated therapeutic targets for Sjogren syndrome and retrieve their cell-type-specific embeddings from PINNACLE. Identify the overlap between these targets and fibroblast-activated genes in PINNACLE to define the cell-type-specific targets. Compute the average embedding of this overlapping set and then calculate the cosine similarity between this average and the embedding of each target. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['DNMT1', 'DEPDC7', 'SOS1', 'HLA-B', 'MTRR']",Sjogren syndrome,fibroblast,HLA-B,"Among the genes DNMT1, DEPDC7, SOS1, HLA-B, and MTRR, which one shows the highest fibroblast-specific expression relevant to targeting Sjögren’s syndrome?","Among the genes DNMT1, DEPDC7, SOS1, HLA-B, and MTRR, which one shows the highest fibroblast-specific expression relevant to targeting Sjögren’s syndrome? Identify validated therapeutic targets for Sjogren's syndrome and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with fibroblast-activated genes in PINNACLE to define the cell-type–specific targets for the syndrome. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between this reference and each individual target. If one gene shows a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based justification for its biological relevance."
"['SMARCC2', 'FBXL6', 'PEBP1', 'LY9', 'ARHGAP1']",Sjogren syndrome,fibroblast,SMARCC2,"Which gene among SMARCC2, FBXL6, PEBP1, LY9, and ARHGAP1 demonstrates the highest fibroblast-specific expression in the context of targeting Sjögren's syndrome?","Which gene among SMARCC2, FBXL6, PEBP1, LY9, and ARHGAP1 demonstrates the highest fibroblast-specific expression in the context of targeting Sjögren's syndrome? Using PINNACLE, retrieve the cell-type–specific embeddings for all verified therapeutic targets for Sjogren syndrome. Next, determine which of these targets overlap with fibroblast-activated genes in PINNACLE to generate a set of cell-type–specific targets. Compute the average embedding for this overlapping set and calculate the cosine similarity between this average and the embedding of each individual target. If one gene exhibits a substantially higher similarity than all others, nominate this gene as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['HRH3', 'RAB32', 'ERGIC3', 'DDX6', 'PLA2G4C']",Sjogren syndrome,fibroblast,DDX6,"Which candidate gene—HRH3, RAB32, ERGIC3, DDX6, or PLA2G4C—demonstrates the greatest fibroblast-specific expression relevant to targeting Sjögren's syndrome?","Which candidate gene—HRH3, RAB32, ERGIC3, DDX6, or PLA2G4C—demonstrates the greatest fibroblast-specific expression relevant to targeting Sjögren's syndrome? Using validated therapeutic targets for Sjogren's syndrome, retrieve their cell-type–specific embeddings from the PINNACLE dataset. Identify the subset of these targets that overlaps with fibroblast-activated genes in PINNACLE. Compute the average embedding for the overlapping set and calculate the cosine similarity between this reference and each individual gene embedding. If one gene shows significantly higher similarity than the others, nominate it as the top candidate and provide a succinct, evidence-based explanation for its biological relevance."
"['MORC2', 'KMT5B', 'DMC1', 'KIAA1671', 'STAT1']",Sjogren syndrome,fibroblast,STAT1,"Among the genes MORC2, KMT5B, DMC1, KIAA1671, and STAT1, which exhibits the highest fibroblast cell-type specificity relevant to Sjogren syndrome?","Among the genes MORC2, KMT5B, DMC1, KIAA1671, and STAT1, which exhibits the highest fibroblast cell-type specificity relevant to Sjogren syndrome? Identify and validate the therapeutic targets for Sjogren syndrome and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with fibroblast-activated genes in PINNACLE, defining this intersection as the cell-type–specific targets for Sjogren syndrome. Compute the average embedding of these overlapping targets, then calculate the cosine similarity between this mean embedding and each individual target. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PPIA', 'UQCRH', 'ZNF664', 'FAM98B', 'ZBTB21']",Sjogren syndrome,fibroblast,PPIA,"Which gene among PPIA, UQCRH, ZNF664, FAM98B, and ZBTB21 exhibits the highest fibroblast-specific expression for targeted studies on Sjögren syndrome?","Which gene among PPIA, UQCRH, ZNF664, FAM98B, and ZBTB21 exhibits the highest fibroblast-specific expression for targeted studies on Sjögren syndrome? Identify the validated therapeutic targets for Sjogren syndrome and obtain their cell-type–specific embeddings from the PINNACLE database. Then, determine which of these targets overlap with the set of fibroblast-activated genes in PINNACLE to compile a candidate list of cell-type–specific therapeutic targets for Sjogren syndrome. Compute the average embedding of this candidate set as a reference vector and calculate the cosine similarity between this reference and each individual candidate embedding. Finally, nominate the gene with the highest cosine similarity as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['STAT1', 'FBXL17', 'FAM72D', 'ODAD3', 'JADE2']",Sjogren syndrome,fibroblast,STAT1,"Among the genes STAT1, FBXL17, FAM72D, ODAD3, and JADE2, which exhibits the highest cell-type specificity in fibroblasts and represents the most promising target for Sjogren's syndrome research?","Among the genes STAT1, FBXL17, FAM72D, ODAD3, and JADE2, which exhibits the highest cell-type specificity in fibroblasts and represents the most promising target for Sjogren's syndrome research? Identify the verified therapeutic targets for Sjögren syndrome and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which fibroblast-activated genes in PINNACLE overlap with these targets to define the cell-type–specific targets for Sjögren syndrome. Compute the average embedding of this overlapping set and calculate the cosine similarity between this average and each individual target. If one gene displays a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its potential biological relevance."
"['SMARCC2', 'ATG12', 'MRFAP1', 'NFE2L1', 'PLIN2']",Sjogren syndrome,fibroblast,SMARCC2,"Among the genes SMARCC2, ATG12, MRFAP1, NFE2L1, and PLIN2, which one exhibits the highest fibroblast-specific expression, making it the most promising candidate for targeting Sjögren syndrome?","Among the genes SMARCC2, ATG12, MRFAP1, NFE2L1, and PLIN2, which one exhibits the highest fibroblast-specific expression, making it the most promising candidate for targeting Sjögren syndrome? Identify the confirmed therapeutic targets for Sjögren syndrome and obtain their cell-type–specific embeddings from the PINNACLE database. Determine which of these targets overlap with the fibroblast-activated genes in PINNACLE, forming a set of cell-type–specific candidates. Calculate the average embedding for this set and then compute the cosine similarity between this reference embedding and each individual target. If one gene exhibits a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological significance."
"['CCDC87', 'ABLIM3', 'C10orf82', 'MAP2K1', 'GTF2I']",Sjogren syndrome,fibroblast,GTF2I,"Among the genes CCDC87, ABLIM3, C10orf82, MAP2K1, and GTF2I, which one shows the highest fibroblast-specific expression relevant for targeting Sjögren syndrome?","Among the genes CCDC87, ABLIM3, C10orf82, MAP2K1, and GTF2I, which one shows the highest fibroblast-specific expression relevant for targeting Sjögren syndrome? Identify validated therapeutic targets for Sjögren syndrome and obtain their cell-type–specific embeddings from the PINNACLE database. Then, determine which of these targets overlap with fibroblast-activated genes in PINNACLE, and compute the average embedding for this overlapping set as a reference point. Calculate the cosine similarity between this reference and each individual gene's embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['GRIP2', 'SAR1A', 'HLA-DRA', 'GRK2', 'CPXM1']",Sjogren syndrome,fibroblast,HLA-DRA,"Among the genes GRIP2, SAR1A, HLA-DRA, GRK2, and CPXM1, which one demonstrates the greatest fibroblast-specific expression relevant to targeting Sjögren's syndrome?","Among the genes GRIP2, SAR1A, HLA-DRA, GRK2, and CPXM1, which one demonstrates the greatest fibroblast-specific expression relevant to targeting Sjögren's syndrome? Identify the validated therapeutic targets for Sjogren syndrome and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets also correspond to fibroblast-activated genes. Calculate the average embedding of this overlapping set to serve as a reference, then compute the cosine similarity between this reference and each individual target’s embedding. Finally, if one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ZNF276', 'DDX6', 'DHX38', 'DNAJA4', 'F7']",Sjogren syndrome,fibroblast,DDX6,"Which gene among ZNF276, DDX6, DHX38, DNAJA4, and F7 exhibits the most fibroblast-specific expression in the context of Sjogren syndrome?","Which gene among ZNF276, DDX6, DHX38, DNAJA4, and F7 exhibits the most fibroblast-specific expression in the context of Sjogren syndrome? Identify validated therapeutic targets for Sjogren syndrome and extract their cell-type–specific embeddings from PINNACLE. Determine which of these targets overlap with the fibroblast-activated genes in PINNACLE. Compute the average embedding for the overlapping set and then calculate the cosine similarity between this average and each individual target embedding. If one gene demonstrates significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['LRTM1', 'NOP53', 'LGALS3', 'ALS2CL', 'NR3C1']",Sjogren syndrome,fibroblast,NR3C1,"Among the genes LRTM1, NOP53, LGALS3, ALS2CL, and NR3C1, which exhibits the highest fibroblast-specific expression, making it the most promising candidate target for Sjögren’s syndrome?","Among the genes LRTM1, NOP53, LGALS3, ALS2CL, and NR3C1, which exhibits the highest fibroblast-specific expression, making it the most promising candidate target for Sjögren’s syndrome? Identify experimentally validated therapeutic targets for Sjogren syndrome and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which fibroblast-activated genes in PINNACLE overlap with these targets, thereby defining a set of cell-type–specific targets for Sjogren syndrome. Compute the average embedding of this overlapping set to serve as a reference, and then calculate the cosine similarity between this reference and the embedding of each individual target gene. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based justification for its biological relevance."
"['FKBP1A', 'ROBO3', 'UVSSA', 'EPB41L1', 'TTYH3']",Sjogren syndrome,fibroblast,FKBP1A,"Among the genes FKBP1A, ROBO3, UVSSA, EPB41L1, and TTYH3, which one demonstrates the highest fibroblast-specific expression relevant to targeting Sjögren's syndrome?","Among the genes FKBP1A, ROBO3, UVSSA, EPB41L1, and TTYH3, which one demonstrates the highest fibroblast-specific expression relevant to targeting Sjögren's syndrome? Identify the verified therapeutic targets for Sjogren syndrome and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, determine the overlap between these targets and the fibroblast-activated genes identified in PINNACLE to obtain a set of cell-type–specific targets. Calculate the average embedding for this overlapping set and compute the cosine similarity between this average and each individual target’s embedding. If a single gene displays a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
